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Zusammenfassung 
 
Transkriptionsfaktoren der Forkhead Box O (FoxO)-Familie sind hochkonserviert und an 
der Regulation zahlreicher zellulärer und physiologischer Prozesse beteiligt, darunter 
Zellproliferation, Apoptose, die zelluläre Antwort auf oxidativen Stress, Langlebigkeit und 
Energiestoffwechsel. Im Kontext der Untersuchungen zur Redoxregulation von FoxO-
Proteinen wird in der vorliegenden Arbeit die Bedeutung von (a) Glutathion und (b) FoxO1-
Cysteinresten für die Modulation der FoxO-Aktivität analysiert. Dafür wurden sowohl 
kultivierte Zellen als auch ein in vivo-Modell, Caenorhabditis elegans (C. elegans) eingesetzt. 
Zunächst wurde der Effekt untersucht, den Diethylmaleat (DEM), eine α,β-ungesättigte 
Carbonylverbindung und thiolmodulierende Substanz, auf die Lebensspanne von C. elegans 
hat. Niedrig dosiertes DEM bewirkte eine Verlängerung der Lebensspannne von C. elegans. 
Unter Einsatz daf-16- oder skn-1-defizienter Stämme sowie über Nachweis der Regulation 
von DAF-16- bzw. SKN-1-Zielgenen wurde sodann gezeigt, dass diese Verlängerung der 
Lebensspanne durch die Transkriptionsfaktoren DAF-16 und SKN-1, C. elegans-Homologe 
von FoxO bzw. Nrf2, vermittelt wird. Im Gegensatz hierzu hatte hochdosiertes DEM keine 
Änderung der Expression von DAF-16- oder SKN-1-Zielgenen zur Folge und verkürzte die 
Lebensspanne signifikant. Auf ähnliche Weise hatte auch Abschwächen der 
Glutathionbiosynthese durch RNA-Interferenz auf Ebene der gcs-1-Expression die gesteigerte 
Expression von Genen zur Folge, die für antioxidative Proteine codieren. 
Zum Zweck der Analyse der Interaktion zwischen Glutathion und einem 
Säugerhomologen von DAF-16, FoxO1, untersuchten wir die Bedeutung von FoxO1-
Cysteinresten für die Regulation der FoxO-Aktivität unter basalen und Stressbedingungen. 
Transfektion von Zellen mit Wildtyp (WT)-FoxO1 oder cysteindefiziente FoxO1-
Formen codierenden Plasmiden führte zur Stimulation FoxO-responsiver Promotoren, die im 
Falle der FoxO1-ΔCys1-7 überexprimierenden Zellen schwächer war als im Falle von WT-
FoxO1. Eine einzelne Mutation in Cys612 vermittelte diese Abnahme der basalen 
Transaktivierungsaktivität von FoxO1, die wiederum zur Folge hatte, dass die Expression von 
FoxO-Zielgenen weniger stark stimuliert wurde als im Falle der Überexpression von WT-
FoxO1.  
Behandlung von Zellen mit Diamid, das S-Glutathionylierung in den Zellen steigerte, 
schwächte die Bindung von WT-FoxO1, nicht aber von FoxO1-ΔCys1-7, an DNA ab. Durch 
Diamid induzierte S-Glutathionylierung wurde durch Überexpression von Glutaredoxin 
(Grx)-1 erfolgreich rückgängig gemacht. Überexpression von Grx-1 beschleunigte die 
Wiederherstellung der DNA-Bindung durch FoxO1. Da lediglich Grx-1 mit intaktem Cys23 
diese Wiederherstellung beschleunigte, während Cys26 hierfür unwichtig war, wurde
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gefolgert, dass S-Glutathionylierung die diamidinduzierte Abnahme der DNA-Bindung durch 
FoxO1 vermittelt. 
Zusammengefasst reguliert durch Thioldepletion hervorgerufener oxidativer Stress 
FoxO-Proteine, was zu einem nicht-linearen Effekt einer Thioldepletion auf die C. elegans-
Lebensspanne führt. Darüber hinaus wurde S-Glutathionylierung als ein Weg identifiziert, 
über den Glutathion die FoxO1-Aktivität unter Stress beeinflusst. 
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Summary 
 
The highly conserved transcription factors of the Forkhead box O (FoxO) family are 
involved in the regulation of several cellular and physiological processes, including cell 
proliferation, apoptosis, oxidative stress response, longevity, and fuel metabolism. Here, in 
the context of the analysis of a redox modulation of FoxO proteins, the role of (a.) glutathione 
and (b.) FoxO1 cysteine residues in modulating FoxO activity were assessed employing 
cultured cells and an in vivo-model, Caenorhabditis elegans (C. elegans).  
Initially, the effects of diethyl maleate (DEM), an α,β-unsaturated carbonyl compound 
and thiol modulating agent, on C. elegans life span were explored. Low-dose-DEM elicited 
an extension of C. elegans life span. Using daf-16 or skn-1-deficient strains and through the 
upregulation of DAF-16 or SKN-1 target genes this life span extension was then 
demonstrated to be mediated by transcription factors DAF-16 and SKN-1, C. elegans 
homologues of FoxO and Nrf-2, respectively. In contrast, exposure to high-dose-DEM did not 
alter the expression of DAF-16 or SKN-1 targets and significantly shortened lifespan. 
Similarly, downregulation of glutathione biosynthesis through RNA interference to lower gcs-
1 expression elicited the induced expression of genes encoding antioxidant proteins.  
In order to analyze the interaction between glutathione and a mammalian DAF-16 
homolog, FoxO1, we investigated the role of FoxO1 cysteine residues in regulating FoxO1 
activity under basal and stressful conditions. In cells transfected with plasmids encoding 
wildtype (WT) FoxO1 or cysteine-deficient FoxO1 forms, stimulation of FoxO1-responsive 
promoters was less prominent in cells overexpressing FoxO1-ΔCys1-7 as compared to those 
transfected with WT FoxO1. A single mutation in Cys612 mediated this loss of basal 
transactivation of FoxO1 activity, which in turn caused less prominent stimulation in 
expression of FoxO1 target genes as compared to overexpression of WT FoxO1.  
Exposure of cells to diamide, which promoted cellular S-glutathionylation, attenuated 
DNA binding of WT FoxO1, but not of FoxO1-ΔCys1-7. Diamide-induced S-
glutathionylation was successfully reversed by overexpression of glutaredoxin (Grx)-1. In line 
with that, Grx-1 overexpression promoted an accelerated recovery of the impaired FoxO1 
DNA binding. As only Grx-1 harboring an intact Cys23 was capable of accelerating recovery, 
whereas Cys26 was irrelevant, it was concluded that S-glutathionylation mediated diamide-
induced attenuation of FoxO1 DNA binding. 
In summary, oxidative stress induced by thiol depletion regulates FoxO proteins, 
resulting in a non-linear effect of thiol depletion on C. elegans life span. Moreover, S-
glutathionylation was identified as one mode of action of glutathione affecting FoxO1 activity 
under stressful conditions. 
                                                                                                                                 Introduction 
1 
 
1. Introduction 
 
1.1 C. elegans as a model organism and its maintenance 
 
Caenorhabditis elegans (C. elegans) was first introduced as model organism by Sydney 
Brenner in 1965, while the first publication was released in 1974 [1]. C. elegans is a small 
round transparent nematode (approx. 1 mm long) with a short life span, high number of 
progeny and relatively simple maintenance and manipulation. Although being evolutionarily 
far away from humans, C. elegans shares approx. 40% gene homology with Homo sapiens 
and therefore several signaling pathways are highly conserved. Thus, C. elegans has emerged 
as a model organism for studies mainly related to ageing and age-related diseases [2]. 
In nature, C. elegans lives in rotting vegetables from where it can be isolated [3]. In 
laboratories, it can be grown and maintained on agar plates spotted with Escherichia coli (E. 
coli). Upon bacteria depletion, an adult worm can utilize its fat supply, whereas in early 
developmental stages may arrest in a dauer stage [4]. Another important factor influencing C. 
elegans growth is temperature; temperatures higher than 25°C result in  accelerated ageing of 
the worms [5]. Interestingly, exposure to high temperature for short periods of time is a 
frequently employed method to increase the amount of males [6]. Wild type C. elegans 
worms are usually grown and maintained at 20°C. 
 
1.2 C. elegans anatomy 
 
Wild type C. elegans has two sexual forms: a self-fertile hermaphrodite (XX) and a male 
(XO). Hermaphrodites are essentially females and are the dominant form; males occur at a 
frequency of 0.1-0.2 %. It should be noted that males are important for exchanging genetic 
material required for the generation of worms with diverse genetic composition. Both sexual 
forms share several similarities but also sex-related differences in their anatomy. An adult 
hermaphrodite has a constant amount of 959 somatic nuclei, of which 302 are neurons. In 
contrast, an adult male has 1033 somatic nuclei, of which 385 are neurons, mainly related to 
male mating behavior. Interestingly, males are thinner and slightly shorter (approx. 0.8 mm) 
than the hermaphrodites [7]. Independent of the gender, the cross section is cyclical with an 
inner and an outer tube separated by the pseudocoelomic space. Cuticle, hypodermis, 
excretory system, neurons and muscles are part of the outer tube and the inner tube consists of 
the pharynx, intestine and, in adult worms, gonad. Cuticle is the outer part of the worm, 
connecting the pharynx with the rectum. Various tissues, such as the excretory pore, vulva 
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and anus penetrate the cuticle. All the previously mentioned tissues are on the ventral side 
(Fig.1). 
 
 
Figure 1:  
General anatomy of a newly hatched L1 hermaphrodite larva. Despite being in such an early stage, the larva has 
already developed most of its tissues. The outer tube consists of the cuticle, hypodermis, excretory system, neurons 
and muscles In contrast to that, the pharynx, intestine and gonad belong to the inner part. Cuticle runs the entire 
body, connecting the pharynx with the rectum and is penetrated by various tissues. Modified figure from Sulton et 
al., 1980; permission obtained from Elsevier [8]. 
 
1.3 C. elegans life cycle and its genome 
 
 
Figure 2: 
C. elegans life cycle at 22°C. Shortly after fertilization, the first cleavage occurs. Following a 9-hour ex utero 
development, the egg hatches and the offspring enters the L1 stage. Under certain conditions, such as food 
shortage, C. elegans might arrest in L1 stage and survive for up to 10 days. Under physiological conditions, four 
post-hatching larval stages are required until adulthood. Under unfavorable conditions, the worm may enter the 
dauer stage where most of its activities are impaired, until the conditions become favorable again. An adult 
hermaphrodite is capable of laying approximately 300 eggs progeny (figure obtained from WormAtlas). 
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C. elegans life cycle is divided in to an embryonic stage and adulthood (Fig. 2). The end 
of each larval stage is characterized by a molting process, in which a new cuticle is 
synthesized that substitutes the old one. During molting, pharyngeal pumping ceases and the 
animal enters a brief lethargus. 
 
1.3.1 Embryogenesis 
 
Embryogenesis can be divided into two stages: proliferation and organogenesis/ 
morphogenesis [9]. Proliferation is then subdivided into two stages: the first phase (0-150 
minutes) covers the time between zygote formation until the generation of founder cells and 
the second phase (150-350 min) covers the period from cell divisions and gastrulation until 
the beginning of organogenesis [10]. Each embryonic stage is characterized by specific cell 
migrations, alterations in number of cells, and synchronized stem-cell divisions. The first sign 
of sexual dimorphism becomes visible at 510 minutes. In late embryogenesis, the embryo has 
already established a main body plan and fully differentiated tissues and organs, which do not 
significantly alter during post-embryonic development [11]. 
 
1.3.2 Post-embryonic development 
 
Three hours after hatching and under favorable conditions, a post-embryonic 
developmental program is initiated [12]. Normally, four larval stages are required until 
adulthood. Progenitor cells are divided in different constant patterns, giving rise to a certain 
number of cells, whose fates are pre-determined [13]. Under unfavorable conditions, such as 
in the absence of food, the young larvae may transition to an arrest stage and survive up to 10 
days. As soon as a food source is again available, these arrested L1 larvae can normally 
progress [14]. 
Among all larval stages, L2 larval stage is unique due to the fact that under unfavorable 
environmental factors, such as absence of food and high temperature, a morphologically 
distinct L2-stage larva (L2d) may be formed [15]. An L2d larva may develop to a L3 larva or 
under unfavorable environmental conditions may form a dauer larva, with a thick cuticle and 
thin shape. On the dauer larval stage, activities, such as pumping and locomotion, are 
impaired. Upon favorable conditions, the worm exits the dauer state and molts to the L4 
stage, after about 10 hours. [15, 16]. 
Approximately 45-50 hours post-hatching at 22°C-25°C, an adult, fertile hermaphrodite 
can lay eggs; fertile period lasts for about 4 days [17]. Following the fertile period, a mature 
adult may live for an additional 10-15 days, depending on environmental conditions. An adult 
hermaphrodite usually produces about 300 eggs of progeny, but upon mating the progeny 
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number can be increased to 1200-1400. Males can successfully mate with a hermaphrodite for 
6 days and be responsible for the birth of approx. 3000 progeny [18]. 
 
1.3.3 C. elegans genome 
 
C. elegans was the first multicellular eukaryotic organism to have its complete genome 
sequenced. Its genome is 100 Mb, containing 20.444 genes coding for proteins, packed in to 
five autosomal chromosomes and one sex chromosome [19]. C. elegans genes do not contain 
big introns and thus are smaller than the vertebrate genes, with an average gene size of 3 kb 
[20]. Most protein-coding mRNAs are trans-spliced and some genes are organized in operons 
[21]. Similar to mammals, C. elegans proteins may also be modified post-translationally 
through ubiquitination, phosphorylation, methylation, and glycosylation [22-24]. 
 
1.4 C. elegans signal transduction 
 
As previously mentioned, several signaling pathways are highly conserved between 
humans and C. elegans. Thus, C. elegans has emerged as useful tool, frequently employed in 
studies related to signal transduction. For instance, Troemel et al. in 1995 described the 
members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) in C. 
elegans [25]. Han et al. in 1990 discovered that let-60 encodes for ras protein [26]. Since then 
the receptor tyrosine kinase/Ras GTPase/mitogen-activated protein kinase (RTK/Ras/MAPK) 
pathway has been linked to several developmental processes in C. elegans (for a 
comprehensive overview, see [27]). The above-mentioned conserved pathways are just a few 
examples of active pathways in C. elegans. Herein, we will focus on DAF-2, the C. elegans 
homolog of insulin/insulin-like growth factor-1 (IGF-1) receptors, signaling pathway, which 
is responsible for DAF-16 modulation. 
 
1.4.1 Insulin/IGF-1 signaling pathway 
 
In mammals, the insulin/IGF-1 receptors are transmembrane receptors which belong to 
the class of receptor tyrosine kinases (RTK) and are activated by insulin and IGF-1, 
respectively [28]. The insulin/IGF-1 signaling pathway is widely conserved and 
phosphorylation-activation of the insulin/IGF-1 receptors by their ligands activates several 
other cascade, such as the phosphoinositide 3-kinase (PI3K)/Akt, Ras/MAPK, and 
mechanistic target of Rapamycin (mTOR) pathways [29, 30]. This insulin cascade is mainly 
responsible for the regulation of processes, like metabolism, growth, development, and 
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longevity. Initially, we will focus on the key components of the pathway in C. elegans, which 
to a great extent are similar to humans too. 
 
1.4.2 Key components of DAF-2-dependent pathways in C. elegans 
 
 
Figure 3:  
DAF-2 (Insulin/IGF-1) signaling pathway in C. elegans. Upon stimulation of the DAF-2 receptor by its ligands 
(black dots), the DAF-2 receptor is activated and phosphorylates AGE-1. AGE-1 will then phosphorylate PIP2 to 
PIP3, which recruits PDK-1 that in turn phosphorylates AKT-1/AKT-2 and SGK-1. Phosphorylated AKT-1 
induces phosphorylation of DAF-16 and SKN-1 and thus promotes their nuclear exclusion (colored red). When 
localized in the cytoplasm PAR-5 and FTT-2 block DAF-16 nuclear relocalization. Upon desphosphorylation of 
DAF-16 and SKN-1, both transcription factors become active and shuttle back to the nucleus, where they bind to 
DNA (colored green). Additionally, DAF-2 phosphorylates DDL-1, which in turn recruits DDL-2 and HSB-1. The 
recruited protein complex blocks nuclear localization of HSF-1 (colored red). As soon as HSF-1 is released from 
the protein complex, it then becomes active, translocates into the nucleus where it binds to DNA. DAF-2, insulin 
receptor homolog; AGE-1, PI3K homolog; DAF-18, PTEN homolog; AKT-1 and AKT-2, Akt homolog; PAR-5 
and FFT-2, 14-3-3 proteins homologues; DAF-16, FoxO family homologues; SKN-1, Nrf-2 homolog. 
 
DAF-2, C. elegans homolog of insulin receptor, and DAF-2 signaling was discovered 
during studies related to dauer regulation and genetic control of longevity [31]. It is now 
widely known that phosphorylated and activated DAF-2 receptor activates a 
phosphatidylinositol 3-kinase (AGE-1). Activated AGE-1 will then phosphorylate 
phosphatidylinositol bisphosphate (PIP2) to phosphatidylinositol trisphosphate (PIP3); DAF-
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18 can dephosphorylate PIP3 and thus antagonizes AGE-1. Then PIP3 recruits 3-
phosphoinositide-dependent protein kinase-1 (PDK-1), which in turn phosphorylates AKT-
1/AKT-2 and serum/glucocorticoid-regulated kinase 1 (SGK-1). Activated AKT-1/AKT-2 
phosphorylates DAF-16 and Skinhead-1 (SKN-1), leading to their nuclear exclusion. When 
DAF-16 is retained in the cytoplasm, PAR-5 and FTT-2 bind to the inactive DAF-16, and 
thus block DAF-16 nuclear translocation [32]. Additionally, activated DAF-2 can directly 
recruit and phosphorylate a DDL-1/DDL-2/HSB-1 complex, inducing the cytoplasmic 
retention of heat shock transcription Factor-1 (HSF-1) (Figure 3) [33]. Through the 
modulation of those transcription factors, the DAF-2 pathway plays a key role in regulating 
several processes, such as the L1 and dauer arrest, germline proliferation, stress resistance, fat 
metabolism, and ageing. Among the modulated transcription factors, herein we will mainly 
focus on DAF-16 and SKN-1.  
 
1.4.2.1 DAF-16 transcription factor 
 
DAF-16, the homolog of the mammalian forkhead box, class O (FoxO) family, is the 
main downstream target of the DAF-2 pathway (Fig. 3) [34]. In C. elegans, daf-16 encodes 
for eight distinct transcripts of which daf-16e and daf-16g encode proteins lacking a DNA 
binding domain and thus their function is elusive. The other six mRNAs are controlled by 
three distinct promoters, which encode for proteins with different N-termini, and are 
comprised in three groups daf-16a, daf-16b, and daf-16d/f/h [35-37]. Each group shows a 
tissue-specific distribution; daf-16a and daf-16d/f/h are active in most tissues, but daf-16b is 
exclusively active in the pharynx, nervous system, and somatic gonad [36, 37]. In line with 
the daf-16a and daf-16d/f/h ubiquitous expression, overexpression of daf-16a-specific and 
daf-16d/f/h-specific transgenes efficiently rescued the dauer-constitutive and longevity 
phenotypes of daf-16-deficient; daf-2 (e1370) double mutants [37]. Among the DAF-16 
isoforms, DAF-16A and DAF-16D/F/H share a higher homology percentage with mammalian 
FoxO proteins as compared to the others. DAF-16A harbors all three RxRxxS/T motifs, 
which are directly phosphorylated by AKT-1/AKT-2; in contrast, DAF-16D/F/H harbors a 
QxRxxS/T motif in the N-terminus, leading to the hypothesis that distinct kinases may 
phosphorylate the two isoforms and thus separately regulate DAF-16A or DAF-16D/F/H [37]. 
A potentially unique regulator of DAF-16D/F/H might be the target of Rapamycin complex 1 
(TORC1) [38]. In addition to the traditional AGE-1/AKT-driven DAF-16 regulation, other 
co-factors and regulators can modulate DAF-16 activity, which to a great extent, have 
homologues in humans (Table 2) [39]. 
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Table 1: Regulators and co-factors modulating DAF-16 indepentently of AGE-1/AKT 
Activators Inhibitors 
Protein Reference Background Protein Reference Background 
AAK-2 [40] Energy homeostasis EAK [41-44] DAF-2 pathway 
CST-1 [45] Oxidative stress RLE-1 [46, 47] Ubiquitylation 
JNK-1 [48] Oxidative stres HCF-1 [49] Cell cycle 
PRMT-1 [50] Methylation    
BAR-1 [51] Oxidative stres    
Sirtuin [52, 53] Deacylation    
CBP-1 [53, 54] Acetylation    
SMK-1 [55] DAF-2 pathway    
DPY-21 [56] X-chromosome 
dosage compensation 
   
TRPA-1 [57] Cation channel    
RHEB-1 [58] Nutrient/energy/ 
redox sensor 
   
Activators and inhibitors acting on DAF-16 independently of AGE-1/AKT. AAK-2, AMPK gamma subunit 
homolog; CST-1, MST-1 homolog; JNK-1, Jnk homolog; PRMT-1, PRMT1 homolog; BAR-1, α, β-catenin 
homolog; CBP-1, p300 homolog; SMK-1, phosphatase 4 regulatory subunit 3A homolog; RHEB-1 Rheb homolog, 
TORC1 activator; RLE-1, Roquin homolog, E3 ubiquitin ligase homolog; HCF-1, host cell factor homolog. 
 
As a transcription factor, DAF-16 binds to a DNA element, TTGTTTAC, known as 
DAF-16 binding element (DBE) and thus upregulates the expression of target genes involved 
in several cellular processes, such as in antioxidant defense, thermotolerance, maintenance of 
metabolic homeostasis, and resistance to heavy metals [59, 60]. These genes belong to the 
“Class 1 DAF-16 targets”. In contrast, the “class 2 DAF-16 targets” contain an alternative 
DNA binding sequence in their promoters, CTTATCA, known as DAF-16 associated element 
(DAE) and thus these genes are downregulated [61]. For the regulation of the “class 2 DAF-
16 targets”, it was recently proposed that the zinc finger transcription factor PQM-1 acts as 
DAE-binding factor, antagonizing DAF-16 [62]. Most genes of the “class 2” are upregulated 
in response to pathogen exposure. In Table 1, five examples of highly regulated genes of each 
class and their potential role are presented, as suggested by Tepper et al., 2013 [62]. 
 
Table 2: Class 1 and Class 2 DAF-16 targets 
Class 1 (upregulated) Class 2 (downregulated) 
Gene Protein function Gene Protein function 
mtl-1  metallothionein-I dct-18 Germline tumor  
ftn-1 ferritin heavy chain F54F11.2a Zinc-binding metalloprotease 
cdr-2  glutathione S-transferase nuc-1 DNAse II homolog;  
apoptotic cell DNA degradation 
sod-3  superoxide dismutase cpr-5 cysteine thiol protease 
gei-7 isocitrate lyase/malate synthase ins-7 insulin-like peptide 
Five examples of the top 50 most upregulated (Class 1) or downregulated (Class 2) transcriptional targets of DAF-
16 as suggested by Tepper et al., 2013 [62]. 
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1.4.2.2 SKN-1 transcription factor 
 
In contrast to its mammalian homolog, nuclear factor-erythroid 2 p45-related factor 2 
(Nrf-2), SKN-1 lacks the ZIP dimerization module, which is required for a stable DNA 
binding [63]. SKN-1 DNA binding domain harbors an additional peptide motif, and thus 
recognizes different bases in the DNA [63, 64]. In C. elegans, the skn-1 gene encodes four 
distinct isoforms of which only three (skn-1a, skn-1b and skn-1c) are also expressed in vivo. 
Among these three isoforms, skn-1a and skn-1c are predominantly expressed in the intestine 
[65, 66]. In contrast, skn-1b is predominantly expressed and localized in the nucleus of the 
two ASI chemosensory neurons [65]. During larval development, minor skn-1a expression 
might be observed in some head neurons [66].  
Regulation of SKN-1 activity can be achieved through different mechanisms in C. 
elegans (Table 3). Typically, SKN-1 regulation depends on PMK-1, C. elegans homolog of 
p38
MAPK
, under oxidative stress. PMK-1 phosphorylates SKN-1 in two residues (Ser164 and 
Ser430), leading to SKN-1 nuclear accumulation and thus affects SKN-1 activity [67]. In 
addition, SKN-1 harbors an RxRxxS/T motif, which can directly be phosphorylated by AKT-
1/AKT-2, inducing SKN-1 cytoplasmic retention (Fig. 3) [66]. Since C. elegans lacks a true 
Keap1 homolog, the interaction between Nrf-2 and Kelch-like ECH-associated protein 1 
(Keap1), which is the major mechanism through which Nrf-2 is inactivated in mammals, 
ubiquitin-mediated proteolysis of SKN-1 in C. elegans occurs through WDR-23, an E3 
ubiquitin ligase substrate adaptor [68-72]. 
 
Table 3: SKN-1 regulators 
Activators Inhibitors 
Protein Reference Background Protein Reference Background 
PMK-1 [67] Oxidative stress AKT-1/AKT-2 [66] DAF-2 pathway 
IRE1 [73] ER-stress WDR-23 [70-72] Ubiquitylation 
   GSK-3 [74, 75] Ubiquitylation 
   SGK-1 [38, 66] DAF-2 pathway 
  
 
mTORC1 [38] 
Nutrient/energy/ 
redox sensoring 
Proteins which modulate SKN-1. PMK-1, p38 homolog; IRE1, Ire-1 homolog; AKT-1/AKT-2, Akt homolog; 
WDR-23, E3 ubiquitin ligase adaptor. 
 
SKN-1 has a pivotal role in defense against oxidative and xenobiotic stress, protein 
homeostasis and metabolism, through the regulation of several genes, some of which are also 
downstream targets of DAF-16 [76-78]. Exposure to acute oxidative stress triggers SKN-1 
accumulation in the nucleus, inducing the expression of various genes involved in all three 
detoxification phases, such as cytochrome P450, short-chain dehydrogenases, glutathione 
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(GSH) biosynthetic, glutathione-S-transferases (GSTs), UDP-glucuronosyl transferases and 
ATP-binding cassette transporters [76, 78-81]. In the absence of oxidative stress, SKN-1 also 
regulates the expression of several genes involved in several processes, such as proteostasis, 
transportation of metals and antimicrobial defense (Table 4) [76]. More specifically, SKN-1 
upregulates the expression of proteasome subunit genes and thus influences proteasome 
activity [77, 82]. In a feedback loop, SKN-1 can both modulate and be modulated by several 
downstream targets of the unfolded protein response (UPR). Interestingly, UPR-driven 
regulation of SKN-1 does not significantly induce SKN-1 nuclear localization, but increases 
the SKN-1 protein levels. Upon UPR, nuclear SKN-1 might regulate its downstream targets in 
cooperation with UPR related factors, such as X-box binding protein-1 (XBP-1) [73].  
 
Table 4: SKN-1 target genes regulated under non-stressed conditions 
Upregulated Downregulated 
Gene Protein function Gene Protein function 
gst-4 Glutathione S-transferase skr-5 SCF ubiquitin ligase,  
Skp1 component 
gst-10  Glutathione S-transferase spp-17 Saposin-like Protein family 
gst-13 Glutathione S-transferase lys-6 N-acetylmuraminidase/lysozyme 
F56A4.4 Glutathione S-transferase ins-7 Insulin-like peptides 
C35B1.5 Thioredoxin, nucleoredoxin 
and related proteins 
dhs-18 Reductases with broad range of 
substrate specificities 
Five examples of the most upregulated or downregulated transcriptional targets of SKN-1 under non-stressed 
conditions as suggested by Oliveira et al., 2009 [76]. 
 
1.5 Reactive oxygen species: a double-edged ax 
 
Both DAF-16 and SKN-1 have a pivotal role in the antioxidant defense through 
regulation of the transcription of several target genes. An imbalance between antioxidants and 
oxidants may cause oxidative stress. Upon oxidative stress, reactive oxygen species (ROS) 
are accumulated, inducing several cellular processes. “ROS” is a term to describe chemical 
species which are formed upon incomplete reduction of oxygen and include superoxide, 
hydrogen peroxide, and hydroxyl radical. Although ROS were originally thought to strictly 
mediate oxygen toxicity, it is now widely accepted that they may also act as intracellular 
signaling molecules, activating pathways involved in cell proliferation, differentiation, and 
survival [83]. Herein we will mainly focus on antioxidant defense in C. elegans and humans. 
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1.5.1 Antioxidant defense in C. elegans 
 
Enhanced oxidative stress resistance was long believed to be the cause of longevity in C. 
elegans. In line with that theory, increased oxidative stress resistance was detected under 
conditions that promote deceleration of ageing, such as in daf-2-deficient mutants or under 
dietary restriction [84, 85]. However, deletion of genes encoding superoxide dismutases (sod 
genes) did not significantly affect life span under the above-mentioned conditions, meaning 
that increased stress resistance is not necessarily required for longevity [86, 87]. Regardless of 
whether induction of stress resistance is the main reason for longevity, regulation of the redox 
state is quite important for survival of C. elegans. 
To regulate its redox state, C. elegans has several antioxidant genes, such as sod, 
catalases, peroxiredoxins etc. For the purpose of this dissertation, we will mainly focus on 
few antioxidant genes, such as sod-3, catalases and genes that code for enzymes involved in 
either the thioredoxin or glutaredoxin system. C. elegans has six different sod genes that 
encode SOD enzymes localized in different compartments. Among these, sod-3, as well as  
sod-2, encodes MnSOD enzymes localized in the mitochondrial matrix [88]. Upregulation of 
sod-3 was predominantly reported in dauers, daf-2-deficient mutants and under oxidative 
stress [86, 89, 90]. It should be noted that strains, in which both Mn- and CuZnSOD were 
knocked down, have similar life span as compared to wild type strains, despite being highly 
sensitive to multiple types of stress, which could potentially be explained through a 
counterbalance between superoxide toxicity and an adaptive response to reduced superoxide 
detoxification [91]. C. elegans contains three catalase enzymes with highly similar sequences 
[92]. CTL-2 seems to be responsible for the majority of the total catalase activity; ctl-2 
depletion leads to reduction of both mean life span and egg-laying capability [92, 93]. 
Surprisingly, overexpression of all catalases leads to life span reduction [86]. In addition, C. 
elegans contains four glutaredoxins (GLRXs), eight thioredoxins (TRXs), and two 
thioredoxin reductases (TRXRs). Knockout of trx-1, which is mainly expressed in specific 
pharyngeal neurons and intestine, induces paraquat resistance but accelerates ageing as 
compared to wild type [94]. On top of that, depletion of trx-1 partially or completely reverses 
longevity driven by daf-2 deletion or dietary restriction, respectively [95]. Genomic analysis 
of C. elegans revealed that 57 genes encode for GSTs. Upon oxidative stress, gst-4 is 
upregulated which in turn increases oxidative stress resistance but does not alter life span 
[96]. Strains overexpressing gst-10, which encodes for a protein which catalyzes the 
detoxification of the lipid peroxidation end-product 4-hydroxynonenal (4-HNE), are more 
resistant to various stressful conditions, such as heat, ultraviolet radiation, and oxidative 
stress, and have an increased life span [97]. However, exclusive increase of HNE-induced 
damage can not sufficiently accelerate ageing in C. elegans [98].  
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1.5.2 Antioxidant defense in humans 
 
All antioxidants can roughly be divided in enzymatic and non-enzymatic. In humans, 
enzymatic antioxidants comprise SODs, catalase, glutathione peroxidases (GPxs), heme 
oxygenase-1, thioredoxins (Trxs), thioredoxin reductases (Trxrs), peroxiredoxins (Prxs), and 
glutaredoxins (Grxs) to name a few [99]. Thiols are among the non-enzymatic scavengers, 
such as GSH, the most abundant non-protein thiol [100]. For the purpose of this dissertation, 
we will mainly focus on glutaredoxins and the non-enzymatic scavenger, GSH. 
 
1.5.2.1 Glutaredoxins, the small redox enzymatic scavengers 
 
Glutaredoxins (Grxs) are small redox enzymes that predominantly use glutathione as a 
co-substrate [101]. Members of this family can be categorized in two groups according to 
their active site motif; the general active site motif is Cys-X-X-Cys and it is present in the 
dithiol Grxs. However, there is another group, known as monothiol Grxs, in which the C-
terminal active site thiol is replaced by a serine (Ser); yet members of this group maintain all 
structural and functional elements to use GSH as co-substrate [102]. In humans, at least four 
Grxs have been identified and they are located in different compartments. The dithiol Grx1 is 
located in the cytosol and is functionally homologues to E. coli and yeast Grx-1. Similarly, 
the predominantly mitochondrial Grx-2 (Grx-2a) is also a dithiol Grx [103, 104]. As a 
consequence of alternative transcription initiation and splicing, two additional Grx2 isoforms 
(Grx-2b and Grx-2c) may also be expressed in testicular cells and in some cancer cells. In 
addition to the dithiol Grxs, two monothiol Grxs (Grx3 and Grx5) are expressed in humans. 
Among all Grxs, only Grx3 contains a Trx-like domain [102]. Grxs may utilize both cysteine 
residues in their active site motif and thus catalyse the reversible reduction of protein 
disulfides [105]. Initially, the N-terminal thiol of the active site motif nucleophilically attacks 
the target disulfide. Afterwards, the mixed disulfide, formed between a Grx and a protein, is 
attacked by the C-terminal thiol of the active site motif. This disulfide in the active site can 
then be reduced by GSH, leading to a mixed disulfide between GSH and the N-terminal 
active site motif thiol. This intermediate mixed disulfide is thereafter reduced by another GSH 
molecule. It is worth to be mentioned that the reduction of disulfides formed between 
glutathione and proteins, which is known as  S-glutathionylation, only requires the Cys 
residue located in the N-terminal part of the active site [102, 106]. S-glutathionylation is a 
post-translational modification and will be reviewed elsewhere. 
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1.5.2.2 Glutathione, the major cellular low-molecular-mass thiol 
 
The non-enzymatic scavengers are mainly low-molecular-compounds, such as vitamins, 
β-carotene, uric acid, and GSH, the most abundant among the low-molecular-mass thiols [99]. 
GSH is a tripeptide and its biosynthesis occurs in two ATP-dependent steps. In the first step, 
γ-glutamylcysteine is formed from glutamate and cysteine, a reaction catalyzed by the 
enzyme γ-glutamylcysteine synthetase (glutamate-cysteine ligase, GCL). This reaction is the 
rate-limiting step in glutathione synthesis [107]. In the second step, the enzyme glutathione 
synthetase adds a glycine to the C-terminus of γ-glutamylcysteine. GSH may be oxidized to a 
disulfide form, glutathione disulfide (GSSG) (Fig. 4), and the GSH to GSSG ratio is often 
used to assess the cellular redox state [108, 109]. GSH is primarily localized in the cytosol; 
yet it can also be found in other compartments, such as in nucleus, mitochondria and ER [110, 
111]. In addition to GSH contributing in to antioxidant defense and detoxification of 
xenobiotics, GSH is also involved in other cellular possesses, such as in  regulation of cell 
cycle progression and apoptosis, storage of cysteine, maintenance of redox status, modulation 
of immune function and fibrogenesis [112-115]. 
 
 
Figure 4:  
Redox couple of glutathione. GSH may serve as an electron donor to reduce disulfide bonds. Upon oxidation, a 
GSH molecule can react with another GSH to form GSSG. Additionally, in a reaction catalyzed by GPx, GSH 
converts hydrogen peroxide to water molecules. In the final products, GSSG is also present [116]. GSSG is 
reduced back to two GSH molecules; this reaction is catalyzed by glutathione reductace [117]. In that reaction, 
NADPH serves as an electron donor. 
 
The antioxidant function of GSH is tightly related to the GPx-catalyzed reaction, in 
which hydrogen peroxide or other hydroperoxides are reduced as GSH is oxidized to GSSG 
[116]. Glutathione reductase can reduce GSSG back to GSH in the presence of NADPH and 
thus a redox cycle is formed [117]. GSH has a pivotal role in defending the cell against 
                                                                                                                                 Introduction 
13 
 
oxidative stress also in mitochondria [118]. Upon severe oxidative stress, GSSG is actively 
exported or  reacts with a protein sulfhydryl group, to prevent a major shift in redox 
equilibrium [119]. 
GSH may also serve as a source of cysteine due to the γ-glutamyl cycle; an extremely 
important function, since cysteine is unstable and rapidly auto-oxidizes. GSH contributes new 
cysteines through the eventual cysteinylglycine hydrolysis by dipeptidase, leading to the 
regeneration of cysteine and glycine. As soon as cysteine is available, it is immediately 
incorporated, mainly into GSH and proteins, by the cells [100]. 
A growing body of evidence points to the association of enhanced GSH levels with a 
proliferative response and is essential for cell cycle progression [114, 119-122]. In 
hepatocytes, during the shift from G0 to G1 phase in vitro, GSH levels are increased; whereas 
blockage of elevated GSH levels significantly impair DNA synthesis [120, 121]. GSH-driven 
maintenance of Trxs and Grxs, which are essential for ribonucleotide reductase activity, the 
rate-limiting enzyme in DNA synthesis, seems to be the mechanism underlying the GSH-
induced modulation of DNA synthesis [123]. Mitogenesis in liver cancer cells was reported to 
be regulated by the upregulation of GSH synthetic enzymes in a cell density-dependent 
manner [121]. Furthermore, reduced conditions mediated by GSH nuclear localization may 
affect the activity of several nuclear proteins, such as histones, and thus influence the cell 
cycle progression [114, 122]. 
GSH has a pivotal role in the regulation of cell death, both in apoptosis and necrosis 
[112, 124-126]. During apoptosis, ROS levels are elevated, leading to GSH oxidation, active 
GSSG secretion, and impaired GCL activity [124, 125]. Additionally, GSH regulates the 
expression/activity of important apoptotic signaling molecules, such as caspase 8 activation 
through tumor necrosis factor (TNF) or nuclear factor-kappa B (NF-κB)-dependent gene 
expression [112, 126]. Moreover, severe mitochondrial GSH depletion leads to elevated ROS 
levels, mitochondrial dysfunction and ATP depletion, which in turn leads to conversion of 
apoptotic to necrotic cells [126]. Lastly, GSH may interfere with various redox-dependent 
signaling pathways, through modifications on protein cysteine residues. 
 
1.6 Protein S-glutathionylation, a post-translational modification 
 
GSH can modify the oxidation state of cysteine residues of several proteins and thus can 
regulate redox-dependent cell signaling. More specifically, GSH can reversibly be bound to 
low-pKa cysteine residues and in turn generate glutathionylated proteins (protein-SSG) 
mainly under oxidative/nitrosative stress, but rarely also under physiological conditions [127]. 
Protein S-glutathionylation is induced mainly through four reactions: i) GSH can directly 
interact with partially oxidized protein sulfhydryls, such as thiyl radical, sulfenic acid, or S-
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nitrosated proteins; ii) thiol/disulfide exchange reactions between protein thiols and GSSG or 
glutathionylated proteins; iii) intermediate S-nitrosothiols can react with protein thiols and 
thus modify protein sulfhydryl groups through either protein S-nitrosation or S-
glutathionylation; iv) in the presence of several oxidants, GSH may directly interact and 
create a disulfide bond with a protein cysteine residue [127-129].  
Protein S-glutathionylation has several roles, related to its reversibility [127]. Upon 
severe oxidative stress, S-glutathionylation protects protein cysteine residues from 
irreversible modifications, which may subsequently lead to proteasomal degradation of 
proteins. Upon oxidative stress alleviation, S-glutathionylated proteins may go back to their 
functional form [127, 130-132]. Additionally, S-glutathionylation may also induce a 
temporary loss of protein function; for instance in case that the modified cysteine residue is 
located on the active site of an enzyme [133, 134]. Moreover, transcription factors, such as c-
Jun and NF-kB may also be inhibited by S-glutathionylation, which in turn may modulate 
gene expression [135-137]. In line with that, Fatelli et al. discovered that genes involved in 
various processes, such as in NF-kB activation, DNA methylation, and induction of cytokine 
production, were regulated in HL60 cells exposed to hydrogen peroxide [138]. Additionally, 
oxidative stress and consequently S-glutathionylation induction in human lung epithelial 
A549 and endothelial ECV304 cells regulates the mRNA levels of several chaperone genes, 
including heat shock proteins, DNA chaperones, and transcriptional regulators [139]. 
Under physiological conditions, S-glutathionylation serves as storage for the rapidly 
oxidized GSH, which may lead to GSSG secretion by the cells [140]. In addition to the 
proteins that undergo S-glutathionylation under oxidative/nitrosative stress, several proteins 
were found to be S-glutathionylated under physiological conditions. Hemoglobin in red blood 
cells, γ-crystallin from human lens, and actin in both human fibroblasts and epidermal A431 
cells are a few examples of constitutively S-glutathionylated proteins [141-145]. Although the 
role of S-glutathionylation under physiological conditions is somewhat elusive, a potential 
role might be involvement in cellular signaling and redox regulation of protein functions. 
Several other proteins were identified as potentially S-glutathionylated; Ballatori et al. 
provide a comprehensive table [112]. 
As already mentioned, one very important aspect that makes S-glutathionylation a 
possible regulatory mechanism is its reversibility. As soon as the redox balance is restored, S- 
glutathionylation may be enzymatically reversed by Grxs and Trxs [127]. Grxs were the first 
to be identified as unique glutathione-mixed disulfide oxidoreductases [146]. Interestingly, in 
the presence of a GS-radical generating system, Grxs may also promote the formation of 
protein S-glutathionylation via distinct mechanisms [127, 147-149]. Deglutathionylation is 
catalyzed by the monothiol pathway, meaning that only the N-terminal cysteine of the Grx 
active site motif is required for this reaction [106]. 
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1.7 FoxO proteins, the mammalian DAF-16 homologues 
 
The “fork head” structure was first discovered in Drosophila melanogaster (D. 
melanogaster) [150, 151]. The same structure was thereafter  recognized in several other 
proteins, such as in the hepatocyte-enriched nuclear factor (HNF)-3A, the first mammalian 
protein identified to harbor that structure, and thus proteins containing such a structure were 
categorized into different classes of forkhead box (Fox) transcription factors [152]. A 
subcategory of the Fox superfamily, FoxO, consists of four ubiquitously expressed members, 
FoxO1, FoxO3a, FoxO4, and FoxO6, which share two highly conserved cysteine residues, of 
which one is localized within the C-terminal transactivation domain (Fig. 5) [153, 154]. 
 
 
Figure 5:  
Domain organization and localization of cysteine residues of FoxO isoforms. Conserved domains, their proposed 
functional role and the localization of cysteine residues are depicted. Total length of each FoxO protein is 
indicated in amino acids (aa) to the right. The numbers next to the domain indicate the beginning and end within 
the sequence. CR1 and CR3, conserved regions 1 and 3; CR3 represents a conserved C-terminal transactivation 
domain; FH/DBD, forkhead box/DNA-binding domain; NLS, nuclear localization signal; NES, nuclear export 
sequence. Numbers in red represent the precise position of cysteine residues. Figure modified from [155].   
 
As already mentioned, a downstream target of the highly conserved insulin (the 
mammalian DAF-2 homolog) pathway is DAF-16, FoxO homolog. In a similar manner, 
stimulation of the insulin receptor leads to phosphorylation of PI3K, AGE-1 homolog, which 
leads to phosphorylation of Akt, AKT-1/AKT-2 homolog. Phosphorylated Akt will then 
phosphorylate members of the FoxO family, leading to their cytoplasmic retention (Fig. 3). 
On the one hand, FoxO transcription factors regulate the expression of several genes involved 
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in antioxidant defense, metabolism, cell death and proliferation. On the other hand, ROS-
mediated post-translational modifications, such as phosphorylation and acetylation and 
interaction with coregulators, which eventually alter subcellular localization, protein synthesis 
and stability may modulate FoxO activity (For a general review about FoxO family see 
[155]). 
 
1.7.1 ROS-driven regulation of FoxO activity 
 
A complex system of several kinases may modulate FoxO activity in response to 
elevated ROS levels through several post-translational modifications or oxidative-stress-
induced interactions with co-factors. Depending on the kinase-driven modification, FoxO 
phosphorylation may lead to either activation or inactivation of FoxO. Additionally, other 
post-translational modifications, like the lysine-related modifications acetylation and 
ubiquitination, may influence the consequences of FoxO phosphorylation upon exposure to 
different stressful stimuli. 
Insulin-driven hydrogen peroxide generation, most likely through activation of NOX4, 
can reversibly oxidize a redox-sensitive cysteine residue of the protein-tyrosine phosphatase 
1B (PTP1B), promoting its inhibition. Interestingly, when PTP1B is activated, it can then 
dephosphorylate the insulin receptor and thus inactivates the insulin signaling pathway, 
creating a feedback loop between insulin receptor and PTP1B, in which hydrogen peroxide 
plays a pivotal role [156-158]. Since FoxO proteins are downstream target of the insulin 
pathway, PTP1B may indirectly modulate FoxO activity. 
In addition to the activation of the insulin receptor, other RTK-dependent signaling, such 
as the extracellular signal-regulated kinases (ERK)-1/2, p38
MAPK
 and JNKs, may eventually 
affect FoxO transcription factors [159-161]. MAPK kinases phosphorylate serines or 
threonines followed by a proline residue and therefore are known as proline-directed kinases. 
Such motifs are frequently found in FoxO proteins, thus there was an assumption that MAPK 
may modulate FoxO activity. Indeed, Yang et al. 2008 showed that ERK-1/2 promotes 
tumorigenesis by phosphorylation/inhibition of FoxO3a, leading to FoxO3a poly-
ubiquitination and subsequent degradation through murine double minute (MDM)-2 [159]. 
Additionally, Erk and p38
MAPK
 phosphorylate/activate Foxo1, promoting a Foxo1/Ets-1 
interaction, which in turns acts on the fetal liver kinase (Flk)-1 promoter in bovine carotid 
artery endothelial cells [160]. Induction of mild oxidative stress activates mediates a JNK-
dependent phosphorylation of FOXO4, leading to its nuclear translocation and transcriptional 
activation [161]. In addition, other proline-directed kinases may modulate FoxO activity [162-
164]. 
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In a less explored field, ROS generation by mitochondria has also been associated with 
FoxO proteins. More specifically, mitochondrial dysfunction mediated by impaired glucose 
metabolism can lead to NOX activation and uncoupling of eNOS and thus to elevated ROS 
levels [165]. In line with that, in human aortic endothelial cells, elevated iNOS levels and 
LDL oxidation was mediated by upregulated FoxO1, under hyperglycemic conditions [166]. 
Additionally, redox-active compounds, such as copper ions (Cu
2+
), doxorubicin, and 
arsenite, may induce ROS elevation and thus potentially affect FoxO activity. In human 
hepatoma cells, exposure to Cu
2+
 phosphorylates/inactivates FoxO1 through activation of the 
insulin signaling cascade and independently of the elevated ROS levels [167]. In line with 
that, other metal ions, such as zinc and cadmium (Zn
2+
 and Cd
2+
, respectively), were also 
reported to stimulate the insulin signaling cascade,  but less prominently as compared to Cu
2+
-
induced stimulation  [167, 168]. In case of Zn
2+
 exposure, direct interaction with PTEN might 
be a potential mechanism underlying the signaling initiation [169]. Furthermore, doxorubicin, 
a DNA intercalating agent and topoisomerase inhibitor which is also known as a ROS-
generator, was shown to induce FoxO3a phosphorylation, leading to nuclear accumulation 
and subsequent activation through p38
MAPK
 in breast cancer cells [170]. In a similar manner,  
exposure to arsenite, a molecule with high affinity towards thiols, induced p38
MAPK
-dependent 
Foxo3a activation, which in turn activated the transcription of Bim (EL), a pro-apoptotic 
protein, in rat pheochromocytoma cells, [171]. Interestingly, arsenite was also reported to 
mediate FoxO phosphorylation/inactivation through the stimulation of insulin cascade 
signaling in human keratinocytes and hepatoma cells, meaning that arsenite-driven 
modulation of FoxO proteins might be cell-dependent [172, 173].   
FoxO activity can also be modulated by ROS-mediated post-translational modifications, 
which can be related to their lysine residues; more predominantly through acetylation and 
ubiquitination. Herein, we will mainly focus on a few aspects of modulation of FoxO activity 
through acetylation and ubiquitination. For a comprehensive review, see [155].  So far seven 
distinct acetylation sites in human FoxO1 and FoxO3a as well as five acetylation sites in 
human FoxO4 and FoxO6 have been identified, which are predominantly localized within the 
highly conserved nuclear localization signal motif and thus the acetylation state may affect 
cytoplasmic/nuclear shuttling, which in turn will modulate transcriptional activity of FoxO 
[34, 155, 174]. Interestingly, in a complex system of molecular mechanisms acetylation may 
both stimulate or inhibit the FoxO transcriptional activity, depending on FoxO isoforms and 
their binding partners, FoxO target genes and cell types used in the individual studies [175-
177].  
It was initially reported that p300-dependent acetylation of FoxO proteins enhances 
FoxO transcriptional activity. Recruitment of p300 to the promoter regions of target genes 
enhanced gene transcription by recruiting the basal transcriptional machinery and by easing 
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chromatin remodeling [178, 179]. In contrast, it was later reported that p300-driven 
acetylation inhibits FoxO transcription activity [180]. 
In addition to the acetylation of lysine residues, ubiquitination may also occur in the 
same lysines, leading to a deacetylation-related ubiquitination of FoxO. In line with that, 
mono-ubiquitination leads to FoxO4 nuclear retention and thus enhanced transcriptional 
activity [181]. In addition, Wang et al. reported that deacetylation of FoxO3a by Sirt1 or Sirt2 
triggers Skp2-triven FoxO3a ubiquitination and subsequent proteasomal degradation [182]. 
Interestingly, when FoxO1 is exclusively phosphorylated at the serine residue S256 by Akt, 
then Skp2 ubiquitinates FoxO1, leading to subsequent proteasomal degradation [183].  
 
1.7.2 FoxO target genes involved in antioxidant defense 
 
FoxO proteins are not just modulated by ROS-driven processes but can also interfere 
with antioxidant defense, through the regulation of various target genes. In humans, Mn-SOD 
(SOD-2), an enzyme which catalyzes dismutation of superoxide to generate oxygen and 
hydrogen peroxide, is regulated by FoxO3a [184]. Additionally, Foxo3 modulates oxidative 
stress through the regulation of Cu, Zn-SOD (SOD-1) in murine erythroblasts [185]. Further 
hydrogen peroxide dismutation is mediated by catalase, which is also regulated by FoxO3a 
[186]. In addition, hydrogen peroxide reduction to water driven by Trx and GSH, reactions 
which are catalyzed by Prx3 and Prx5, in case of Trx-driven reduction, or GPx-1, in case of 
GSH. Interestingly, Prx3, Prx5 and GPx were reported to be regulated by FoxO proteins [185, 
187, 188].  
Furthermore, hydrogen peroxide may be reduced to generate the highly aggressive 
hydroxyl radical, in the presence of Fe
2+
 or Cu
+
, which may be prevented by chelation, for 
instance by ferritin and metallothioneins, respectively [155]. As already shown, C. elegans 
metallothionein-1 and ftn-1 belong to the Class I DAF-16 target genes (Table 1) [62]. In 
mammals, AMPK-induced FoxO3a phosphorylation/activation upregulates mRNA levels of 
metallothionein [189]. Furthermore, ceruloplasmin, the major plasma copper protein which 
acts as ferroxidase to oxidize Fe
2+
 to Fe
3+
 and also allows for transport of Fe
3+
 by transferrin, 
is regulated by FoxO [190-192].  
Lastly, selenoprotein P, the major plasma selenoprotein which predominatly acts as 
transporter of selenium from the liver to extrahepatic tissues through blood, and which is 
encoded by SEPP1 gene, is regulated by a protein complex of peroxisomal proliferator 
activated receptor-γ coactivator 1a (PGC-1a)/FoxO1a/hepatocyte nuclear factor 4 alpha 
(HNF-4a) [193-197]. In addition to the traditional role of selenoprotein P, it can also act as a 
hydroperoxidase activity and thus may prevent low-density lipoprotein oxidation [198, 199].  
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1.8 Aims 
 
A growing body of evidence supports the hypothesis that an unbalanced redox state of 
cells may affect FoxO activity, through post-translational modifications, interaction with 
coregulators, alterations in subcellular localization, protein synthesis and stability [155]. At 
the organismal level, such as in C. elegans, mild oxidative stress inhibits the DAF-2 signaling 
pathway and thus increases stress resistance, which in turn may promote longevity. The 
majority of phenotypes mediated by daf-2-deficiency are driven by activating DAF-16, the 
FoxO homolog in C. elegans. An approach to interfere with the redox state is by using agents 
affecting the thiol status of cells and/or organisms. Thiol modulating agents, such as diethyl 
maleate (DEM) or diamide may interact with protein cysteine residues or low-molecular-thiol 
such as GSH [200, 201]. Although thiol (cysteine) residues of FoxO were previously shown 
to be essential for stress-induced interaction with co-factors that eventually affect FoxO 
activity, the potential GSH contribution in modulating FoxO activity was never directly 
investigated  [177, 202, 203]. 
 
Therefore, the current work had the following aims: 
 
a) To assess whether DEM-induced thiol reduction may affect stress resistance and in 
turn decelerate ageing in C. elegans.  
b) To examine the underlying mechanism mainly focusing on DAF-16 contributions 
and whether genetic GCL depletion, the enzyme catalyzing the rate-limiting step 
in glutathione synthesis, may alter the expression level of DAF-16 target genes 
and other related genes, which may potentially be affected [204]. 
c) To investigate the contribution of FoxO1 cysteine residues on key aspects of 
FoxO1 activity, such as cytoplasmic/nuclear shuttling, DNA binding, and 
transactivation activity, under physiological conditions.  
d) To address the potential contribution of S-glutathionylation to the regulation of 
FoxO1 DNA binding under stressful conditions. 
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2. Material and methods 
 
2.1 Materials 
 
2.1.1 In vivo and in vitro models, cell culture material and employed agents 
 
C. elegans strains were obtained by from Caenorhabditis Genetics Center (CGC, 
University of Minnesota, USA), which is supported by the National Institutes of Health-
Office of Research Infrastructure Programs: wild-type Bristol N2; EU31 [skn-1(zu135)]; 
CF1038 [daf-16(mu86)]. E. coli strains OP50 and OP50i were also received from CGC. E.coli 
HT115 gcs-1 clones were derived from an Ahringer library (Source BioScience, Nottingham, 
UK) [205].  
Human embryonic kidney (HEK293) and human hepatoma (HepG2) were obtained from 
the German collection of microorganisms and cell cultures (DSMZ, Braunschweig, 
Germany). Cell culture medium (low glucose Dulbecco’s modified Eagle’s medium; Cat. No. 
D6046), 1x 0.05 % Trypsin/EDTA (Cat. No. T3924), Penicillin/Streptomycin (Cat. No. 
P4333), MEM non-essential amino acids (Cat. No. M7145) and PBS (Cat. No. D8537) were 
acquired from Sigma-Aldrich (Munich, Germany). FBS Superior (Cat. No. S0615) was 
obtained by Biochrom (Berlin, Germany). TurboFect (R0531, Thermo Fisher Scientific) and 
GenJet (Cat. No. SL100489, tebu-bio) transfection reagents were employed for transfecting 
HEK293 and HepG2 cells, respectively. 
Thiol modulating agents, such as diamide (Cat. No. D3648), diethyl maleate (DEM) 
(Cat. No. D97703) and N-ethylmaleimide (NEM) (Cat. No. E1271) were obtained from 
Sigma-Aldrich. All compounds were dissolved and/or diluted in DMSO. In each case, DMSO 
was 0.1% v/v unless stated otherwise. 
 
2.1.2 Plasmids 
 
Plasmids encoding WT FoxO1 or a FoxO1 cysteine-deficient mutant (FoxO1-ΔCys1-7) 
containing biotinylation and a V5 tag were generated by Keshav Gopal (Klotz group). WT 
FoxO1 and FoxO1-ΔCys1-7 tagged with GFP were previously generated in the Klotz lab. 
Variants of the cysteine-deficient FoxO1 mutant were then generated by subclones of an 
EcoRI/XbaI fragment of FoxO1.  WT FoxO1 and FoxO1-ΔCys1-7 tagged with EGFP were 
generated as depicted in Figure 6. SelP-Luc was previously generated in the Klotz lab [193], 
as well as FoxO1-Luc (unpublished). G6Pase-Luc was a kind gift from Dr. Andreas Barthel 
[206]. FHRE-Luc construct and pCI Neo were obtained from Addgene [207]. Renilla 
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luciferase control plasmid was obtained from Promega (pRL-SV40). Glutaredoxin cloning in 
the pBud vector was performed as depicted in Figure 7. Glutaredoxin variants were generated 
by a site-directed mutagenesis kit. 
 
 
Fig. 6 
Schematic cloning of FoxO1 in the pEGFP-C1 vector. FoxO1 was reversibly transcript from a FoxO1 template 
(FoxO1-V5; “amplify 389 .. 2350”) using the following primers CTTGTCGACGCCGAGGCGCCTCAGGTG 
(primer 1) and CCCGGATCCGCCTCACACCCAGCTATGTGT (primer 2). After isolation from an agarose gel 
the amplicon was digested with SalI and BamHI. The same restriction enzymes were then employed for digestion 
of the pEGFP-C1 vector (Clontech). Eventually, the two fragments were ligated. Numbers next to restriction 
enzymes names represent the positions that the enzymes digested either the vector or the amplicon.  
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Fig. 7 
Schematic cloning of glutaredoxin in the pBUD-CE4 vector. Glutaredoxin was reversibly transcript from a cDNA 
template (“amplify 33 .. 363”) using the following primers GCGAAGCTTGCAGCCCATCGCCATGGCT (primer 
1) and CGCGGATCCCTGCAGAGCTCCAATCTGC (primer 2). After isolation from an agarose gel, the 
amplicon was digested with HindIII and BamHI. The same restriction enzymes were then employed for digestion 
of the pBud-CE4 vector (Thermo Fisher Scientific). Eventually, the two fragments were ligated. Numbers next 
to restriction enzymes names represent the positions that the enzymes digested either the vector or the amplicon.  
 
Table 5: FoxO1 and glutaredoxin plasmids 
Plasmids Vector Assay 
WT FoxO1 
pcDNA3.2/capTEV-NT/V5-DEST 
Luciferase 
Western blotting 
RT-qPCR 
FoxO1 cysteine-deficient mutants 
WT FoxO1 
pcDNA/DEST53 EMSA 
FoxO1-ΔCys-1-7 
WT FoxO1 
pEGFP-C1 Localization 
FoxO1-ΔCys-1-7 
Glutaredoxin 
pBUD-CE4 
Western blotting 
EMSA 
Glutaredoxin cysteine-deficient 
mutants 
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2.1.3 General materials 
 
Table 6: Kits 
Kit Provider Catalog Number 
4x SuperSignal West PICO Thermo Fisher Scientific 34080X4 
BCA Protein Assay Thermo Fisher Scientific 23227SPCL 
Chemiluminescent Nucleic Acid 
Detection Module Kit 
Thermo Fisher Scientific 89880 
Dual-Luciferase
®
 Reporter Assay 
System 
Promega E1960 
LightShift EMSA Optimization 
and Control Kit 
Thermo Fisher Scientific EN0521 
Nuclear Extract Kit Active Motif 40010 
Phusion Site-Directed Mutagenesis Thermo Fisher Scientific F541 
RNase-free DNase set QIAGEN 79254 
RNeasy Mini Kit QIAGEN 74104 
SuperSignal West Femto Max  Thermo Fisher Scientific 34096 
 
Table 7: Antibodies 
Antibody Species Provider Catalog Number 
Anti-V5 Epitope Tag Rabbit (pc) Merck-Millipore AB3792 
b-Actin (13E5) Mouse (mc) Cell Signaling 3700 
Pierce Glutathione (D8) Mouse (mc) Thermo Fisher Scientific MA1-7620 
Myc-Tag (9B11) Mouse (mc) Cell Signaling 2275 
anti-mouse IgG-HRP (sec.) - Santa Cruz Biotechnology sc-2005 
anti-rabbit IgG-HRP (sec.) - Santa Cruz Biotechnology sc-2004 
(pc) polyclonal and (mc) monoclonal antibody; (sec.) secondary antibody 
 
Table 8: Sequences of primers for reverse transcriptase quantitative-PCR  
Gene Species Primer’s Sequence in 5’ → 3’ direction 
act‐1 C. elegans 
ATCAAGATCATCGCCCCACC (fwd) 
GCCGGACTCGTCGTATTCTT (rev) 
ctl‐1 C. elegans 
TCGTTCATGCCAAGGGAGC (fwd) 
GATCCCGATTCTCCAGCGAC (rev) 
ctl‐2 C. elegans 
GAAGGTGTTGGATACCGGGG (fwd) 
GGATGAGTGCCTTGACACGA (rev) 
egl‐1 C. elegans 
AGATCAGCAGCATCGGCTAC (fwd) 
CATGGGCCGAGTAGGACATC (rev) 
gcs-1 C. elegans 
TGTGAACGTCGATGAAGCCA (fwd) 
TCCACGGAAGATTGGTGTGG (rev) 
gei-7 C. elegans 
CTGCCATCTCCGTGGTATCC (fwd) 
ACCCATGTTCCATCGTGTCC (rev) 
gst-4 C.elegans 
GCCCGTGATGATTTCTTGGC (fwd) 
GCCCAAGTCAATGAGTCTCCA (rev) 
gst-10 C.elegans 
ATCCAACGAGCAAGAGGCAA (fwd) 
ACTTCACTAGAGCCTCCGGG (rev) 
sod-3 C.elegans 
CCACCTGTGCAAACCAGGAT (fwd) 
TGCAAGTAGTAGGCGTGCTC (rev) 
trx-1 C.elegans 
ATGTCGATGAAGCGGAAGAT (fwd) 
TTTGACGCAGTTCGTCCTC (rev) 
trxr-1 C.elegans CAAGCGACAGCCGAGACAA (fwd) 
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ACTCGCTGCTACTCCCATAGA (rev) 
trx-2 C.elegans 
CTCAACCGTCGGGTTAACTG (fwd) 
TCGATCGAATCTTCTCCATGT (rev) 
mtl-1 C.elegans 
TCATGGCTTGCAAGTGTGAC (fwd) 
CACAGCAGTACTTCTCACAACACTT (rev) 
g6pc H. sapiens 
TTCCCTGTAACCTGTGAGACTG (fwd) 
AGATGGAAAGAGTAGATGTGACCAT (rev) 
selP H. sapiens 
GGAGCTGCCAGAGTAAAGCA (fwd) 
ACATTGCTGGGGTTGTCAC (rev) 
foxo1 H. sapiens 
TTCCTTCATTCTGCACACGA (fwd) 
TGAAAGACATCTTTGGACTGCTT (rev) 
HPRT-1 H. sapiens 
GGGGACATAAAAGTAATTGGTGGAG (fwd) 
CTGACCAAGGAAAGCAAAGTCTG (rev) 
(fwd) forward and (rev) reverse primer 
 
Table 9: Chemicals and/or Reagents 
Chemical and/or Reagent Provider Catalog Number 
2-Mercaptoethanol Sigma-Aldrich M3148 
2-Vinylpyridine 97% Sigma-Aldrich 132292 
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) 
Sigma-Aldrich M2128 
5-Sulfosalicylic acid dihydrate Sigma-Aldrich S2310 
5,5-dithio-bis-(2-nitrobenzoic acid) DTNB 
(Ellman's Reagent) 
Carl Roth 6334.2 
100x Halt Phosphatase Inhibitor Cocktail Thermo Fisher Scientific 78420 
100x Halt Protease Inhibitor Cocktail Thermo Fisher Scientific 87786 
Acrylamide/Bisacrylamide Rotiphorese® 
Gel 30 
Carl Roth 3029.1 
Agar-Agar BioScience Carl Roth 6494.4 
Agar Bacteriology grade AppliChem A0949 
Ammonium acetate Carl Roth T872.1 
Ampicillin sodium salt Sigma-Aldrich A9518 
Boric acid Carl Roth 6943.1 
Bromophenol blue Carl Roth A512.1 
BSA (fatty acid free) Sigma-Aldrich A8806 
Calcium chloride dihydrate AppliChem A3587 
Cholesterol Sigma-Aldrich C3045 
Dimethyl sulfoxide (DMSO) Carl Roth A994.1 
Ethanol (96%) VWR 20821.310 
Ethylenediamine tetraacetic acid disodium 
salt dehydrate (EDTA) 
Carl Roth 8043.2 
Glutathione Reductase from baker's yeast 
(S. cerevisiae) 
Sigma-Aldrich G3664 
Glycerin Carl Roth 7530.4 
di-Potassium hydrogen phosphate Carl Roth P749.1 
Glycine Carl Roth 0079.4 
IPTG dioxane-free Thermo Fisher Scientific R0392 
Isopropanol Carl Roth CP41.4 
HybondTM-NX Amersham Biosciences RPN303 T 
Hydrochloric acid 25 % Carl Roth 6331.3 
LB Broth Base (Lennox L Broth Base) Invitrogen 00006232 
L-Glutathione reduced Sigma-Aldrich G6529 
L-Glutathione oxidized Sigma-Aldrich G4376 
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Magnesium sulphate heptahydrate Carl Roth P027.1 
Methanol VWR 20864.320 
Milk powder Carl Roth T145.3 
Sodium chloride Carl Roth 3957.2 
NADPH tetrasodium salt Carl Roth AE14.3 
NP-40/Igepal CA-630 Sigma-Aldrich I7771 
Pepton Carl Roth 8952.2 
Potassium dihydrogen phosphate Carl Roth 3904.1 
PVDF membrane 0.2 µm Roche 03 010 040 001 
PVDF membrane 0.45 µm Carl Roth T830.1 
Nystatin 2-hydrate  AppliChem A3811 
SDS pellets Carl Roth CN30.3 
Sodium-deoxycholate Sigma-Aldrich D6750 
SsoAdvanced™ Universal  
SYBR
®
 Green Supermix 
BioRad 172-5275 
Streptavidin Magnetic Beads New England Biolabs S1420S 
Streptomycin sulfate AppliChem A1852 
Triethanolamine Carl Roth 6300.1 
Tris Carl Roth 5429.3 
Tris-HCl Carl Roth 9090.3 
Tween-20 Sigma-Aldrich P1379 
TRIzol
®
 Reagent  Life Technologies 155966026 
Yeast extract Sigma-Aldrich 70161 
 
2.1.4 Buffers and solutions 
 
C. elegans-related general buffers and maintenance 
 
Calcium phosphate buffer (pH 6.0): 200 mM K2HPO4, 800 mM KH2PO4 
Nystatin: 10 mM nystatin, 3.75 M ammonium acetate, 50% v/v ethanol 
S-basal (pH 6.0): 100 mM NaCl, 0.1 w/v K2HPO4, 0.6 w/v mM KH2PO4 
 
NGM plates: 17% w/v Agar-Agar, 2.5% w/v Pepton, 3% w/v NaCl, 0.05% v/v of 1 M CaCl2, 
0.1% v/v of 5 mg/ml of Cholesterol, 0.1% v/v of 1 M MgSO4, 2.5% v/v of Calcium 
phosphate buffer, 0.5% v/v of Nystatin 
DYT (bacterial growth medium): 16% w/v Pepton, 5% w/v NaCl, 10% w/v Yeast extract 
LB medium: 20% w/v LB Broth Base 
LB-agar plates: LB medium, 12% w/v Agar 
 
MTT assay 
 
MTT Solution: 5 mg/ml MTT in PBS  
Solubilization reagent: 37% HCl/Isopropanol at a ratio 1/1000, (HCl 0.01 N/Isopropanol) 
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Western blotting analysis 
 
RIPA buffer: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% v/v NP-40/Igepal CA-630, 0.5% 
w/v Na-deoxycholate, 0.1% w/v SDS 
2x Laemmli buffer: 125 mM Tris-HCl (pH 6.8), 20%v/v Glycerin, 4%w/v SDS, 10%v/v β-
mercaptoethanol, 0.01%w/v Bromophenol blue 
Separation Gel buffer: 1.5 M Tris-HCl (pH 8.8), 0.4%w/v SDS 
Stacking Gel buffer: 0.5 M Tris-HCl (pH 6.8), 0.4%w/v SDS 
10x Running buffer (pH 8.3): 1.92 M glycine, 250 mM Tris, 1%w/v SDS 
10x Transfer buffer (pH 8.3): 1.92 M glycine, 250 mM Tris 
1x Transfer buffer (working solution): 1x Transfer buffer, 20%v/v methanol 
10x  Tris-buffered saline (TBS) (pH 7.5): 1 M Tris (pH 7.6), 1.5 M NaCl  
1x TBS-T (working solution): 1x TBS, 0.1%v/v Tween 20 
Blocking solution: 5%w/v milk in 1x TBS 
Primary antibody: 0.5% w/v milk or BSA in 1x TBS-T, primary antibody diluted 1:1000 
Secondary antibody: 0.5% w/v milk in 1x TBS-T, secondary antibody diluted 1:5000 
 
Electrophoretic mobility shift assay (EMSA) 
 
5x TBE buffer: 450 mM Tris, 450 mM boric acid, 10 mM EDTA 
 
2.2 Methods 
 
2.2.1 C. elegans maintenance and synchronization 
 
Nematodes were grown and maintained at 20°C on nematode growth medium (NGM) 
agar plates spotted with E. coli OP50 as food source, as described elsewhere [1]. For 
maintenance, at least five L4 larval stage nematodes were transferred routinely every fifth (in 
case of skn-1-deficient mutants every seventh) day. Synchronization of worms was performed 
by washing out maintenance plates with double-distilled H2O, followed by centrifugation 
(1300xg, 1 minute, room temperature) to separate the eggs from the nematodes. The last step 
was performed at least twice. The obtained eggs were then transferred to fresh NGM agar 
plates and allowed to hatch. 64 hours post-hatching, nematodes were transferred to fresh 
NGM agar plates containing the respective compounds and processed for the respective assay, 
as described elsewhere. 
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2.2.2 Life span assays 
 
Life span analyses were performed at 20°C. Age-synchronized, 64 hours old nematodes 
were manually transferred to NGM agar plates spotted with E. coli OP50 and supplemented 
with the respective compound or solvent. In case of life span analyses with heat-inactivated 
bacteria, E. coli OP50 were inactivated for 45 minutes at 65°C.  For the first 10 days, worms 
were transferred daily to avoid overcrowding and for separation of adults nematodes from 
their offspring. Only in case of skn-1-deficient strain, nematodes were transferred only on day 
7 and day 10. Following the reproductive period, nematodes were transferred every second 
day. From the beginning of day 12 and onwards, nematodes were transferred to NGM agar 
plates containing 200 μg/ml of streptomycin, the respective compound or solvent, and 
covered with the streptomycin-resistant E. coli strain OP50i to avoid contamination. Worms 
showing no movement, no reaction to gentle stimulation and no pharyngeal pumping were 
scored as dead. Worms lost or disintegrated due to internal hatchings were censored. 
Experiments were performed in quintuplicates for at least two independent times, unless 
stated otherwise. 
 
2.2.3 DTNB assay 
 
Age-synchronized, 64 hours old wild-type worms were washed with S-basal, followed 
by centrifugation (200xg, 1 minute, room temperature). That step was repeated twice and 
thereafter nematodes were transferred to NGM agar plates containing the respective 
compounds and spotted with E. coli OP50 for up to 3 hours. Nematodes were then washed out 
of the plates, centrifuged (200xg, 1 minute, room temperature) once and pellets were shock-
frozen in liquid nitrogen. Shock-frozen pellets were lysed by grinding in liquid nitrogen and 
adding 250 µL of S-basal containing proteinase inhibitors. After sonication (7 cycles, 70% 
power, 5 seconds), the lysed pellets were centrifuged (12000xg, 5 minutes, 4°C) and 
supernatants containing thiols were collected. Amounts of thiols were assessed by convention 
of Ellman's reagent, 5,5′-dithiobis (2-nitrobenzoic acid) (DTNB), to TNB2− [208]. Absorbance 
of thionitrobenzoate released was measured at 412 nm, related to GSH standards and 
normalized to protein content of each lysate. Protein content of lysates was assessed using 
Bradford solution [209]. Absorbance was measured with a CLARIOstar plate reader (BMG 
LABTECH, Baden-Württemberg, Germany). 
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2.2.4 RNA extraction and RT-qPCR in C. elegans 
 
Age-synchronized, 64 hours old wild-type worms were distributed to NGM agar plates 
supplemented with the respective compounds and spotted with E. coli OP50. In case of gcs-1-
specific RNA interference (RNAi) experiments, nematodes were distributed to NGM agar 
plates containing 1 mM isopropyl-β-D-thiogalactoside (IPTG), 100 µg/ml ampicillin and, if 
necessary, 12.5 μg/ml tetracycline and spotted with E. coli HT115 containing L4440 empty 
vector or L4440 carrying a gcs-1 cDNA fragment. Nematodes were then washed daily, 
without centrifugation, and transferred to fresh NGM agar plates containing the respective 
compounds, until the day of harvesting as indicated. Worm pellets were collected and shock-
frozen in liquid nitrogen.  
Total RNA was isolated using TRIzol reagent and thereafter DNA hydrolysis on-column 
was performed using RNEasy Mini Kit and RNase-Free DNase (QIAGEN). RNEasy Mini kit 
was used according to the manufacturer’s instructions; incubation with DNase was performed 
according to the manufacturer’s instructions, with minor modifications (mixture of 5 μl of 
RNase-free DNase I and 35 μl of RNase-free Buffer RDD was employed for 30 minutes at 
room temperature). The RNA content was assessed spectrophometically using a 
SPECTROstar
NANO
 plate reader (BMG LABTECH). 500 ng of RNA was reversely 
transcribed using RevertAid Reverse Transcriptase (Thermo Scientific) according to the 
manufacturer’s instructions. The resulting cDNA template was diluted 1:2 in RNase-free 
water and then subjected to qPCR analysis using SsoAdvanced Universal SYBR Green 
Supermix (5 μl SYBR Green, 0.2 μl of a 5 μM forward primer, 0.2 μl of a 5 μM reverse 
primer, and 1μl of the diluted cDNA template for 40 cycles at an annealing temperature of 
60°C) and a CFX Connect cycler (BioRad Laboratories, Kabelsketal, Gernamy). The 
employed pairs of primers are described in table 7. 
 
2.2.5 Bacterial growth assay 
 
From Lysogeny broth (LB) containing agar plates freshly streaked with E. coli, a single 
colony was picked and inoculated in a glass tube containing 5 ml of LB medium overnight at 
37°C under constant shaking of 150 rpm. Next day, from the initial inoculum an appropriate 
amount to achieve an optical density of 0.5 (OD 600 nm) was pipetted in an Erlenmeyer flask 
containing 50 ml of LB medium and bacteria grew at 37°C under constant shaking of 150 rpm 
for 5 hours. Respective compound or solvent was administrated in the lag or just before the 
exponential phase. Optical density (OD 600 nm) was measured every 20 minutes in cuvettes 
using SPECTROstar
NANO
 plate reader (BMG LABTECH).  
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2.2.6 Maintenance of cell cultures and seeding 
 
HEK293 and HepG2 cells were held at 37°C in a humidified atmosphere with 5% v/v 
CO2 and cultured in low glucose Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% v/v fetal calf serum and 1% v/v penicillin/streptomycin (100 units/ml 
and 0.1 mg/ml, respectively). In case of HepG2 cells, medium was additionally supplemented 
with 1% v/v non-essential amino acids. Cell lines were routinely split as soon as they have 
reached approx. 90-100% confluence. Upon 90-100% confluence, cells were washed once 
with prewarmed PBS and trypsinized either for 1 (for HEK293 cells) or 5 (for HepG2 cells) 
minutes. Trypsinization was performed at 37 °C in a humidified atmosphere with 5% v/v CO2 
and cells were then resuspended in the respective prewarmed DMEM. A certain amount of 
cell suspension was transferred to a new flask containing the respective prewarmed fresh 
DMEM and placed back to the incubator. 
Fully confluent 75 cm
2
 flasks containing HEK293 or HepG2 cells were trypsinized as 
described above and cells were then resuspended to a final volume of 10 ml of the respective 
prewarmed DMEM. Cells were then seeded: (a.) in the wells of a 6-well plate in a final 
volume of 1 ml/well for localization experiments, luciferase reporter assays, expression of 
target genes, viability assay and western blotting analysis, (b.) in 60 mm dishes in a final 
volume of 5 ml/dish for GSH determination, and (c.) in 100 mm dishes in a final volume of 
10 ml/dish for EMSAs and streptavidin pull downs, and thereafter were placed back in the 
incubator. In case of transfected cells, HEK293 were transfected with TurboFect, at a ratio 1/2 
(1 μg of plasmid/2 μl of reagent). HepG2 cells were transfected with GenJet at a ratio 1/3 (1 
μg of plasmid/3 μl of reagent). In both cases, incubation was performed according to the 
manufacturer’s instructions. 
 
2.2.7 Localization assay 
 
Upon approx. 70% confluence post-seeding, HEK293 cells were transfected with 1 μg of 
plasmids encoding WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP. Similarly, HepG2 cells were 
transfected with 2 μg of plasmids encoding WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP. In 
both cases, a 24-hour incubation was performed according to the manufacturers’ instructions. 
Following the incubation, analysis of each treatment was performed as followed: treatment 
was performed with the respective compound or solvent for up to 30 minutes in 1 ml of a 
prewarmed fresh serum-free DMEM followed by DMEM aspiration and subcellular 
localization of FoxO1-EGFP was assessed immediately on the plates; for one individual 
treatment representative pictures were obtained within less than 5 minutes. As soon as the 
acquiring of pictures for one treatment was complete, then another treatment was analyzed as 
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described above right after the 24-hour incubation. In both HEK293 and HepG2 cells, at least 
200 cells were assessed and scored according to the predominant subcellular localization of 
the EGFP signal in “cytoplasm or nucleus or cytopslasm/nucleus using fluorescence 
microscopy (NIS-Elements microscope, Nikon; GFP filter, in excitation 475-495nm, and 
emission 520-560nm). 
   
2.2.8 Luciferase assay 
 
As soon as HEK293 cells reached 70% confluence post-seeding, they were transfected 
with 0.6 μg of the respective luciferase promoter constructs, 0.1 μg of renilla luciferase 
control plasmid and 0.6 μg of the respective FoxO1 expression plasmids or control plasmid. 
HepG2 cells were transfected with 0.9 μg of the respective luciferase promoter constructs, 
0.15 μg of renilla luciferase control plasmid and 0.9 μg of respective FoxO expression variant 
plasmids or control plasmid. FoxO1 expression plasmids contained a biotin and a V5 tag. In 
both cases a 24-hour incubation was performed according to manufacturers’ instructions. 
Following the incubation cells were lysed on ice with lysis buffer provided by a Dual-
Luciferase
®
 Reporter Assay System kit (Promega), according to the manufacturer's 
instructions. 10 μl of each sample was then analyzed in a 96-well plate according 
manufacturer’s instructions, with minor modifications (50 μl of Luciferase Assay Reagent II, 
50 μl of Stop & Glo® Reagent were added by pipetting). Luminescence was assessed within 
less than 2 minutes after the addition of the respective reagent using a CLARIOstar plate 
reader (BMG LABTECH). 
 
2.2.9 RNA extraction and RT-qPCR in human cell lines 
 
Upon approx. 70% confluence post-seeding, HEK293 cells were transfected with 1 μg of 
plasmids encoding WT FoxO1 or FoxO1-ΔCys1-7. Similarly, HepG2 cells were transfected 
with 2 μg of plasmids encoding WT FoxO1-EGFP or FoxO1-ΔCys1-7. Plasmids were tagged 
with biotin and V5. In both case a 24-hour incubation was performed according to the 
manufacturers’ instructions. Following the incubation, total RNA was isolated using RNEasy 
Mini Kit (QIAGEN), according to the manufacturer’s instructions. DNA hydrolysis using 
RNase-Free DNase (QIAGEN) was performed according to the manufacturer’s instructions, 
with minor modifications (mixture of 5 μl of RNase-free DNase I and 35 μl of RNase-free 
Buffer RDD was employed for 30 minutes at room temperature). The RNA content was 
assessed spectrophotometrically using a SPECTROstar
NANO
 plate reader (BMG LABTECH). 
500 ng of RNA was reversely transcribed using RevertAid Reverse Transcriptase (Thermo 
Scientific) according to manufacturer’s instructions. The resulting cDNA template was 
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diluted 1:2 in RNase-free water and then subjected to qPCR analysis using SsoAdvanced 
Universal SYBR Green Supermix (5 μl SYBR Green, 0.2 μl of a 5 μM forward primer, 0.2 μl 
of a 5 μM reverse primer, and 1μl of the diluted cDNA template for 40 cycles at an annealing 
temperature of 60°C) and a CFX Connect cycler (BioRad Laboratories). The employed pairs 
of primers are described in table 7. 
 
2.2.10 MTT assay 
 
Upon 90-100% confluence post-seeding, HEK293 cells were treated with the respective 
compound or solvent for up to 30 minutes in 1 ml of a prewarmed fresh serum-free DMEM. 
Following the incubation, serum-free DMEM was replaced, without intermediate washing, 
with 1 ml prewarmed fresh serum-free DMEM containing 0.25 mg/ml of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and incubated for 2 hours in 
the incubator. To solubilize the resulting blue formazan precipitate, 6 ml of solubilization 
solution was added, followed by 30 minutes incubation on a shaker. Absorbance of the 
blueish solution was measured using a CLARIOstar plate reader (BMG LABTECH), at a 
wavelength of 570 nm. MTT conversion to the formazan was taken as representative of cell 
viability. 
 
2.2.11 Glutathione determination 
 
After seeding in 60 mm dishes and as soon as cells reached 90-100% confluence, 
HEK293 cells were then treated with the respective compound or solvent for up to 30 minutes 
in 5 ml of a prewarmed fresh serum-free DMEM. Following the treatment, cells were washed 
once with prewarmed PBS, harvested in 250 μl of ice-cold 0.01N HCl and stored at -20°C. 
Next day, cells were thawed on ice and supernatants were collected after centrifugation 
(1200xg, 10 minutes, 4°C). Total glutathione and glutathione disulfide amounts were then 
assessed enzymatically as described in [210] using a CLARIOstar plate reader (BMG 
LABTECH). Prior to that step, BCA Protein Assay kit was employed for protein 
determination. For glutathione determination, proteins were precipitated from the supernatant 
with 5% w/v 5-sulfosalicylic acid (original stock solution 20% w/v) of on ice. GSSG levels 
were assessed after blocking thiols with 2-vinylpyridine, using 5,5′-dithionitrobenzoic acid in 
the presence of NADPH and glutathione reductase. 
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2.2.12 Western blotting and pull down with streaptvidin beads 
 
Upon 90-100% confluence post-seeding, HEK293 cells were treated with the respective 
compound or solvent for up to 30 minutes in 1 ml of a prewarmed fresh serum-free DMEM. 
Following the incubation, cells were washed once with prewarmed PBS and lysed in RIPA 
buffer supplemented with a protease and phosphatase inhibitor cocktail and 25 mM N-
ethylmaleimide (NEM). Cell lysates were then sonicated (5 cycles, 70% power, 5 seconds) 
and supernatants were collected after centrifugation (12000xg, 5 minutes, 4°C). Protein 
determination was assessed using BCA protein assay kit according to the manufacturer’s 
instructions. In case of transfected cells, upon approx. 70% confluence post-seeding, cells 
were transfected with 1 μg of FoxO1 variant plasmids or with 2 μg of either Grx-1 variant 
plasmids or empty pBudCE4.1 vector and incubated for 24 hours in the incubator. For 
transfection, a vector containing a biotinylation signal and a V5 tag (pcDNA3.2/capTEV-
NT/V5-DEST) or a vector containing a myc tag (pBudCE4.1) in case of FoxO1 or Grx-1 
variants were employed, respectively. Following a 24-hour incubation, transfected cells were 
processed as described above. In case of experiments requiring post-treatment recovery, 
serum-free DMEM containing the respective compound was replaced with prewarmed fresh 
DMEM, without an intermediate washing, and cells were incubated for the respective periods 
of time in the incubator. 
20 μg of protein were mixed with the appropriate volume of 2x or 5x Lämmli buffer with 
or without β-mercaptoethanol, according to the requirements of the individual experiments 
and boiled at 95°C for 5 minutes. Lysates were analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using 10% gels. Electrophoresis was 
performed at 80 to 100 V and thereafter the separated proteins were transferred to a PVDF 
membrane with 0.45 μm pores using wet (tank) blotting. Transfer was carried out at constant 
voltage of 100 V for 2 ½ hours at 4°C. The PVDF membrane was incubated in 5% milk 
dissolved in TBS (blocking solution) for 1 hour on a shaker at room temperature. Following 
blocking, the membrane was probed with primary antibody overnight at 4°C. The next day, 
the membrane was washed thrice for 5 minutes with TBS-T and incubated with the secondary 
antibody for at least 1 hour and again washed thrice for 5 minutes with TBS-T. All steps were 
carried out on a shaker at room temperature. Then, the membrane was incubated with an 
enhanced chemiluminescence reagent (ECL) for 1 minute and subsequent development using 
a ChemiDoc
TM
 MP Image System (BioRad). Following development, the membrane was 
washed for at least 1 hour with TBS-T and reprobed with another primary antibody overnight 
at 4°C for yet another detection, as previously described. In case of detection of Grx-1 
variants, 18% gels and PVDF membrane with 0.2 μm pores were employed. Transfer was 
performed at constant voltage of 90 V for 2 hours at 4°C. 
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In case of a pull down with streptavidin magnetic beads, 25 μl of the beads were added to 
100 μl of a total protein lysates in RIPA buffer and the mixture was then incubated under 
constant rotation at 4°C overnight. Following the overnight incubation, biotinylation signal-
containing proteins were pulled down according to the manufacturer’s instructions 
(Streptavidin Magnetic Beads, New England Biolabs). Pulled down proteins were then 
analyzed using western blotting, as previously described. 
 
2.2.13 Electrophoretic mobility shift assays (EMSA) 
 
Upon approx. 70% confluence post-seeding, 5 ml of the initial 10 ml of DMEM in the dish 
were removed and cells were transfected with 5 μg of plasmids encoding FoxO1 variants and 
incubated for 24 hours in the incubator. Thereafter, transfected cells were treated with the 
respective compound or solvent for up to 30 minutes in 15 ml of a prewarmed fresh serum-
free DMEM. Thereafter, treatment was removed and nuclear extracts were generated using a 
cell fractionation kit (Nuclear Extract Kit, Active Motif) according to the manufacturer’s 
instructions. Protein content of the nuclear extracts was assessed using a BCA protein assay 
kit according to the manufacturer’s instructions. For transfection with plasmids encoding 
FoxO1 or Grx-1 variants, 5 μg of each of the respective plasmid was employed. In case that 
co-transfection of WT FoxO1 with either Grx-1 variant plasmids or empty pBudCE4.1 vector 
was required, 3 μg of WT FoxO1 and 7 μg of Grx-1 variants were used. For transfection, a 
vector containing a GFP tag (pcDNA/DEST53) or a vector containing a myc tag 
(pBudCE4.1) in case of WT FoxO1 or Grx-1 variants were employed, respectively. In 
addition, in experiments requiring post-treatment recovery, serum-free DMEM containing the 
respective compound was replaced with prewarmed fresh DMEM, without an intermediate 
washing step, and cells were incubated for the respective time points in the incubator. 
A mixture containing 1 μl 10x binding buffer, 0.5 μl of each of the following 
components, poly (dIdC), glycerol, NP-40, KCl (all reagents were part of the LightShift 
EMSA Optimization and Control Kit, Thermo), 2 μg of protein nuclear extract, 24 pmol of 
competitor in case it was required for the experiment, and double distilled H2O in a final 
volume of 9.2 μl was incubated for 10 minutes at room temperature according to the 
manufacturer’s instructions (LightShift EMSA Optimization and Control Kit, Thermo). 
Following the 10-minute incubation, 80 fmol (original stock solution 100 fmol/µl) of a 
biotinylated probe were added and the mixture was incubated for another 30 minutes. The 
biotinylated probe was a double stranded DNA with the following sequence: 5’-
CAAAACAACAAAACAACAAAACAA-3’, 5’-TTGTTTTGTTGTTTTGTTGTTTTG-3’. 
Thereafter, 2.5 μl of the loading dye was added. Samples were analyzed using a native 4.2% 
polyacrylamide gel, which was pre-run at constant 100 V for 1 hour. Electrophoresis was 
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performed at constant 30 mA for up to 5 hours on ice. Following electrophoresis, transferring 
to a pre-equilibrated hybond membrane (HybondTM-NX, Cat. No. CRPN303 T, Amersham 
Biosciences) was at constant 100 V for 15 minutes on ice. Post-transfer, crosslinking of the 
membrane was performed under ultraviolet light (312 nm, VL-6.LM bulb, Biotechnologie 
GmbH) in approx. 2 cm distance for 10 minutes and the membrane was then processed for 
detection using a Chemiluminescent Nucleic Acid Detection Module Kit (Thermo) according 
to the manufacturer’s instructions. Development of the membrane was performed using the 
ChemiDoc
TM
 MP Image System (BioRad). 
 
Ms. Maria Landrock, M. Sc., contributed to viability assay (twice), GSH determination 
(twice), the western blotting analysis of the WT FoxO1 and FoxO-ΔCys1-7 (twice) and the 
establishment of the electrophoretic mobility shift assay (EMSA). 
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3. Results 
 
3.1 DEM treatment leads to depletion of total thiols in C. elegans  
 
Initially, effects of different DEM concentrations on the thiol status in C. elegans were 
assessed (Fig. 8). DEM is an α,β-unsaturated carbonyl compound able to form adducts with 
thiols and to serve as a substrate for glutathione S-transferases, meaning that it can deplete but 
not necessarily oxidize GSH [200].  
 
Figure 8:  
DEM-induced depletion of total thiols in C. elegans. Age-synchronized, 64 hours old wild-type worms were 
transferred to NGM agar plates containing the respective DEM concentration or solvent (DMSO 0.1% v/v). 
Following a 3-hour incubation, the total amount of thiols was assessed using DTNB. Thiol/protein level ratios 
were calculated and normalized against the control (0 μΜ DEM), which was set to 100%. Data are presented as 
means +SEM from 3 independent experiments. *p<0.05 as compared to control; Student´s t-test. 
 
Although exposure to low DEM concentrations (up to 10 μΜ) led to a non-significant 
depletion of total thiols, an approximate 25% decrease in thiol content was detected upon 
exposure of worms to higher DEM concentrations (up to 1 mM). No real concentration-
dependent pattern in thiol depletion was detected at 100 μM DEM and above, but treatment 
with 1 mM DEM induced statistically significant thiol depletion (Fig. 8). As DEM was able to 
deplete thiols in C. elegans, we further investigated the effect of DEM exposure on C. elegans 
life span. 
 
3.2 Mild thiol depletion may enhance C. elegans life span 
 
To test for the effect of thiol depletion on C. elegans life span, worms were exposed to 
different DEM concentrations and the consequence for life span was assessed (Fig 9). 
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Figure 9:  
Effects of DEM treatment on C. elegans life span. (A) Representative life span curve of an individual experiment 
and (B) overall mean life span of three experiments are depicted. Age-synchronized, 64 hours old wild-type 
nematodes were transferred to NGM agar plates containing the respective DEM concentration or solvent (DMSO 
0.1% v/v), and their survival rates was monitored at 20°C. Experiments were carried out in quintuplicates and were 
performed thrice. (A) 100 μM (green) p<0.01 and 1 mM (red) p<0.001 as compared to control (0 μΜ black); log-
rank test. (B) Data are presented as means ±SEM from 3 independent experiments; control (DMSO 0.1%v/v 
treatment) was set to 100%; **p<0.01 as compared to control; ***p<0.001 as compared to control; Student´s t-
test. 
 
In line with the observed thiol alterations (Fig. 8), administration of low DEM 
concentrations (up to 10 μΜ) did not significantly affect life span. However, exposure of 
worms to 100 μΜ DEM significantly increased both mean and maximum life span. In 
contrast to the 100 μΜ-mediated deceleration of ageing, exposure to 1 mM DEM shortened 
nematode life span, leading to a non-linear impact of thiol depletion on C. elegans life span 
(Fig. 9). It should be noted that, because no significant difference in overall thiols (Fig. 8) was 
detected between 100 μM  and 1 mM DEM (concentrations that caused alterations of C. 
elegans life span),  total amounts of thiols might not be the most suitable marker to determine 
effects that thiol modulating agents could potentially have on C. elegans viability. As C. 
elegans was held and grown on bacteria, and as bacterial viability is known to affect C. 
elegans life span, we tested whether the observed effect might be due to an interaction of 
DEM with the thiols of bacteria. We therefore analyzed bacterial growth in the presence of 
DEM (Fig. 10) and determined C. elegans life spans using heat-inactivated bacteria (Fig. 11). 
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Figure 10:  
Effect of DEM exposure on OP50 E. coli growth. The effect of 100 μΜ (green) and 1 mM (red) DEM or solvent 
(DMSO 0.1% v/v; black line) when administrated in (A) the lag or (B) just before the exponential phase of 
growing bacterial inocula (OP50 E. coli) was studied at 37°C. Each graph is representative of an individual 
experiment; each experiment was performed twice and same results were acquired.  
 
 
Figure 11:  
Effect of DEM exposure on C. elegans life span, upon feeding with heat-inactivated bacteria. The life span curves 
of an individual experiment are depicted. Age-synchronized, 64 hours old wild-type nematodes were transferred to 
NGM agar plates containing the respective DEM concentration or solvent (DMSO 0.1% v/v), and their survival 
rates was monitored at 20°C. Experiment was carried out in quintuplicates and was performed twice; same results 
were acquired. 100 μΜ DEM (green) n.s and 1 mM DEM (red)  p<0.001 as compared to control (black 0 μΜ 
DEM); log-rank test. 
 
Administration of 100 μΜ DEM either in the lag (Fig. 10A) or just before the 
exponential phase (Fig. 10B) did not affect bacterial growth. In contrast, exposure to 1 mM 
DEM inhibited bacterial growth. Moreover, in worms fed with heat-inactivated bacteria, 
exposure to DEM at concentrations as low as 10 μΜ increased both mean and maximum life 
span; but treatment with 1 mM DEM significantly diminished life span. Exposure to 100 μM 
did not significantly affect C. elegans life span (Fig. 11). We hypothesized that DEM was not 
actively taken up by bacteria and thus more of the compound was potentially available for the 
worms, which might explain the somewhat shifted hormetic effect, since less than 100 μM 
DEM might be required to promote deceleration of ageing. Since low DEM concentrations 
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did not affect bacteria, implying that worms were not held under an “artificial” caloric 
restriction at these DEM concentrations, we further investigated the mechanism underlying 
the life span modulating effect of DEM. For the upcoming experiments, we mainly focused 
on DEM concentrations causing alterations in C. elegans life span (100 μΜ or 1 mM DEM), 
while worms were fed with living bacteria. 
 
3.3 Low-dose-DEM elicited C. elegans life span extension through DAF-16 and SKN-1  
 
To identify the mechanism underlying the DEM-driven effect C. elegans life span 
extension, the potential contribution of DAF-16 and SKN-1 was investigated (Fig. 12). We 
hypothesized that the DEM-mediated effects in C. elegans life span might be triggered by 
increased stress resistance. DAF-16 and SKN-1, C. elegans homologues of FoxO and Nrf-2 
respectively, are two transcription factors of major importance in the regulation of stress 
resistance and longevity. Therefore, we employed two distinct strains in which either daf-16 
or skn-1 were inactivated [155, 204]. 
 
Figure 12:  
Contributions of DAF-16 and SKN-1 to DEM-mediated effects on C.elegans life span. Representative life span 
curve of an individual experiment of (A) daf-16 (mu86)-deficient and (B) skn-1 (zu 135)-deficient mutants are 
depicted. Age-synchronized, 64 hours old type nematodes were transferred to NGM agar plates containing 100 μM 
(green) or 1 mΜ (red) DEM concentration or solvent (DMSO 0.1% v/v; black), and their survival rates was 
assessed at 20°C. Experiments were carried out in quintuplicates. Experiments with 100 μΜ DEM were performed 
(A) thrice and (B) twice; 1 mM DEM was only analyzed in one experiment in both cases. (A.) 100 μM DEM n.s 
and 1 mM DEM p<0.01 as compared to control (black); log-rank test. (B.) 100 μM, n.s and 1 mM p<0.001 as 
compared to control; log-rank test. 
 
The increase in life span induced by 100 μM DEM in wild type worms was abolished, 
whereas the toxic effect (1 mM DEM) was not alleviated in the daf-16-deficient mutant (Fig. 
12A). A similar observation was obtained in the skn-1-deficient mutant (Fig. 12B). Therefore, 
the 100 μΜ-induced effect of DEM, but not the one elicited by 1 mM, might require both 
transcription factors to be mediated. To further evaluate the obtained result, the expression 
levels of various DAF-16 and/or SKN-1 target genes in C. elegans were analyzed. 
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3.4 Low-dose-DEM dose caused upregulation of DAF-16 and SKN-1 target genes 
 
We analyzed the expression of genes known to be modulated by DAF-16 and SKN-1, 
mainly focusing on genes which could contribute to antioxidant defense and stress response 
(Fig. 13). Target genes, such as ctl-1, sod-3, gei-1 (also known as icl-1) are known to be 
regulated by DAF-16 [60, 62]. Moreover, gcs-1, gst-4, and gst-10 are mainly regulated by 
SKN-1 [76]. Since both DAF-16 and SKN-1 are downstream targets of insulin/IGF-1, they 
often share target genes, such as ctl-2 [60, 81]. As DEM-driven thiol depletion and oxidative 
stress might induce DNA damage, we also studied the mRNA levels of egl-1, a gene 
regulated by CEP-1, the C. elegans p53 homolog [211].  
In line with the results obtained by the daf-16 or skn-1-deficient mutants, upregulation of 
DAF-16 or SKN-1 target genes was detected in nematodes treated with 100 μΜ DEM. In 
contrast, no significant alteration was observed upon exposure to 1 mM DEM (Fig. 13). The 
majority of peak mRNA levels was detected after 3-7 days of 100 μM DEM treatment, which 
is in line with an adaptive response being induced by low DEM concentrations, resulting in 
upregulation of antioxidant genes as well as genes involved in GSH metabolism. In contrast 
to the upregulation of both DAF-16 and SKN-1 target genes upon treatment with 100 μΜ 
DEM, exposure to 1 mM strongly upregulated egl-1 mRNA levels (Fig. 13H). Exposure to 1 
mM DEM seemed to cause damage to an extent that induction of DAF-16/SKN-1-dependent 
genes was no longer possible and thus signaling processes related to programmed cell death 
were stimulated. 
In addition to the reduction in total thiols, DEM successfully depleted GSH following a 
5-day exposure [204]. According to the time course, DEM seemed to initially create adducts 
with protein thiols and thereafter with GSH, meaning that the use of DEM might not be the 
optimal approach to identify potential contributions of GSH to regulation of C. elegans life 
span. To further elucidate the role of GSH, we genetically manipulated GSH biosynthesis.      
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Figure 13:  
Expression of DAF-16 and SKN-1 target genes in C.elegans exposed to DEM. Relative mRNA level of (A.-C.) 
predominantly DAF-16-regulated genes, (E.-G.) predominantly SKN-1-regulated genes (D.) ctl-2 is regulated by 
both transcription factors, and (H.) egl-1, a p53-regulated gene, are depicted. Age-synchronized, 64 hours old wild-
type nematodes were exposed to 100 μΜ (green), 1000 μM (red) DEM concentration or solvent (DMSO 0.1% v/v, 
black), for the indicated time points at 20°C. Thereafter nematodes were harvested and RNA was isolated. The 
mRNA levels were determined using RT-qPCR and normalized over act-1 mRNA levels (a housekeeper gene); 
DMSO control was then set to 100. Data are means of 3 independent experiments + SEM (*p<0.05 as compared to 
control; **p<0.01 as compared to control; Student´s t-test). 
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3.5 Regulation of redox-related genes upon attenuation of GSH biosynthesis 
 
To attenuate GSH de novo biosynthesis, we directly knocked out gcs-1 mRNA, using an 
RNAi approach. In C. elegans, gcs-1 encodes for the catalytic subunit of GCS-1, the rate-
limiting enzyme in GSH biosynthesis. In addition to a significant GSH reduction, 
administration of gcs-1-specific RNAi to L4 adult nematodes throughout the entire life span 
enhanced stress resistance which in turn led to a significant increase in mean and maximum 
life span [204]. To test whether the DEM-like effects of GSH depletion had similar 
downstream targets, ctl-1, sod-3, and gst-4 regulation was investigated. Moreover, the 
potential contribution of genes encoding either members of the thioredoxin-dependent redox 
system, such as trx-1, trxr-1, and trxr-2 or proteins highly enriched with cysteine residues, 
such as metallothioneins (mtl-1), was also assessed (Fig. 14) [212, 213].  
Initially, and as expected, administration of gcs-1-specific RNAi successfully 
downregulated gcs-1 expression as compared to nematodes fed with the empty control vector 
L4440 (Fig. 14A). Inhibition of gcs-1 did not significantly affect the expression level of DAF-
16 target genes, such as sod-3, and ctl-1 (Fig 14B and C). In contrast, remarkable 
upregulation in the expression of genes encoding for proteins that could potentially 
complement the action of GSH, such as thioredoxins or metallothioneins, which in turn could 
contribute to antioxidant protection and redox regulation of cellular processes was detected 
(Fig. 14E-H). 
Although, low-dose-DEM mediated (a.) depletion of glutathione (data not shown) and 
(b.) elevation in the expression of DAF-16 and SKN-1 transcriptional targets evolved in C. 
elegans antioxidant defense (Fig. 13), a direct manipulation of GSH, causing an approximate 
50% depletion (data not shown), DAF-16 transcriptional activity was not significantly 
affected (Fig 14B and C). Since DEM can also form adducts with cysteine residues of 
proteins, leading to depletion of overall thiols (Fig. 8), we further investigated whether direct 
manipulation of cysteine residues of FoxO1, the mammalian DAF-16 homolog, may affect 
several aspects of FoxO1, such as cytoplasmic-nuclear shuttling, DNA binding, and 
transactivation activity.  
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Figure 14:  
Expression of DAF-16 and SKN-1 target genes and other redox-modulated genes following gcs-1 depletion in 
C.elegans. Relative mRNA levels of (B.-D.) predominantly DAF-16 or SKN-1-regulated genes, (E.-H.) redox-
modulated genes/thioredoxin system genes and mtl-1 (A.) gcs-1 expression, are depicted. Age-synchronized, 64 
hours old wild-type nematodes were incubated for the indicated time points on agar plates, supplemented with 100 
μg/ml ampicillin and 1 mM IPTG and spotted with E. coli HT115 containing empty vector L4440 (black) or vector 
containing a gcs-1 cDNA fragment (blue). Respective mRNA levels were assessed by RT-qPCR and normalized 
over act-1 mRNA levels as a housekeeper; empty vectors were set to 100. Data are means of 3 independent 
experiments +SEM (*p<0.05 as compared to L440; **p<0.01 as compared to L440; Student´s t-test). 
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3.6 Contribution of FoxO1 cysteine residues in its activity under basal conditions 
 
In an attempt to mimic the DEM interaction with cysteine residues of proteins, we 
genetically manipulated FoxO1 cysteine residues (all cysteines were mutated to serines) 
through site-directed mutagenesis. FoxO1 harbors seven cysteine residues, of which two 
(Cys23 and Cys612) are highly conserved among the FoxO isoforms (Fig. 7). Similar to its C. 
elegans homolog, FoxO1 is a transcription factor shuttling between the cytoplasm and the 
nucleus. In addition to cytoplasmic-nuclear shuttling, DNA binding and transactivation 
activity may interfere with FoxO1 activity and therefore these aspects were tested in a 
cysteine-deficient mutant under basal conditions in HEK293 and HepG2 transfected cells. 
 
3.6.1 Neither localization nor DNA binding were affected in cysteine-deficient FoxO1  
 
 FoxO1 DNA binding was analyzed through EMSA. HEK293 cells were transfected with 
plasmids encoding either wild type FoxO1 (WT FoxO1)-GFP or cysteine-deficient FoxO1 
(FoxO1-ΔCys1-7)-GFP (Fig. 15). Moreover, HEK293 and HepG2 cells were transfected with 
plasmids encoding either WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP, and subsequently 
their cytoplasmic-nuclear shuttling was assessed (Fig. 16). 
 
Figure 15:  
Basal FoxO1 DNA binding in HEK293 transfected cells. (A) Representative EMSA depicting either WT FoxO1 or 
FoxO1 ΔCys1-7 DNA binding and (B) statistical analysis of four individual experiments. Nuclear extracts of 
HEK293 cells transfected with WT FoxO1-GFP or FoxO1-ΔCys1-7-GFP were generated using cell fractionation 
kit and thereafter DNA binding of FoxO1 was assessed using EMSAs. The competitor represents an unlabeled 
with biotin probe. (B) Data are presented as means +SD from 4 independent experiments. 
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Figure 16:  
Basal FoxO1 localization in HEK293 and HepG2 transfected cells. Examples of cells with basal FoxO1-EGFP 
distribution in compartments in (A.) HEK293 and (B.) HepG2 cells. WT FoxO1-EGFP and FoxO1-ΔCys1-7-
EGFP are represented in “i.” and “ii.”, respectively. (C.) Analysis of basal FoxO1-EGFP distribution among 
compartments. HEK293 or HepG2 cells were transfected with WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP and 
basal FoxO1-EGFP distribution in compartments was assessed using fluorescence microscope. (C.) Data are 
presented as fractions of 100% of 3 independent experiments. In all cases, SD was lower than 5% of the relative 
amount of cells, as were set to 100%. 
 
Initially, as determined using EMSAs, FoxO1 cysteine deficiency did not significantly 
impair FoxO1 DNA binding in HEK293 cells, in which different FoxO1-GFP forms were 
overexpressed (Fig. 15). That observation is in line with the absence of cysteine residues in 
the FoxO1 DNA binding domain (Fig. 7). The overall distribution of FoxO1 in compartments 
was somewhat different between the two cell lines. In HEK293 cells, FoxO1 was 
predominantly localized in the cytoplasm, whereas FoxO1 was ubiquitously distributed in 
HepG2 cells (Fig. 16). A potential explanation might be the constitutive phosphorylation of 
Akt only in HEK293 cells, which in turn could cause FoxO1 cytoplasmic retention under 
basal conditions (data not shown). Despite the differential FoxO1 distribution between the 
two cell lines, FoxO1-ΔCys1-7 followed the same distribution pattern as WT FoxO1 (Fig. 
14). As neither nucleocytoplasmic distribution nor DNA binding of FoxO1 was altered by 
FoxO1 cysteine deficiency, yet another aspect of FoxO1, its transactivation activity, was 
studied. 
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3.6.2 Basal transactivation activity of FoxO1 depends on its Cys612 residue 
 
To investigate basal FoxO1 transactivation activity, the stimulation of FoxO1-responsive 
promoter constructs in cells overexpressing either WT FoxO1-V5 or FoxO1-ΔCys1-7-V5 
tagged with biotin was assessed by luciferase reporter assay (Fig. 17). Promoter constructs 
which are known to be activated by FoxO1, such as FHRE-Luc, G6Pase-Luc, SelP-Luc and 
FoxO1-Luc, were employed [174, 193, 206, 207].  
 
Figure 17:  
Stimulation of FoxO1-responsive promoters in HEK293 and HepG2 cells, transfected with different FoxO1 forms. 
HEK293 or HepG2 cells were co-transfected with different FoxO1-related promoter constructs and various 
expression vectors as indicated. Cells were then lysed and processed for detecting stimulation of FoxO1-
responsive promoters using luciferase reporter assay. Promoter constructs were conjugated with a firefly luciferase 
and as internal control renilla luciferase was employed. Firefly luciferase/renilla luciferase ratio was calculated and 
then WT FoxO1 was set to 100. As a “control vector”, pCI Neo was employed. All FoxO1 expression vectors were 
tagged with biotin and V5. G6Pase Luc was not assessed in HEK293 cells due to low g6pc expression levels. Data 
are presented as means +SD from 3 independent experiments. *a, p<0.001 as compared to control vector; *b, 
p<0.001 as compared to WT FoxO1; One-way Anova with Student-Newman-Keuls post-test. 
 
Although overexpression of FoxO1-ΔCys1-7 successfully stimulated FoxO1-responsive 
promoters as compared to cells transfected with an control vector, and in contrast to the intact 
nucleocytoplasmic distribution (Fig. 16) and DNA binding (Fig. 15), stimulation of FoxO1-
responsive promoters in cells overexpressing FoxO1-ΔCys1-7 was less prominent as 
compared to those transfected with WT FoxO1 (Fig. 17). To elucidate which cysteine is 
responsible for the impaired transactivation activity, additional Cys-deficient mutants were 
employed. In summary, overexpression of a mutant harboring a mutation only in Cys612 
(FoxO1-ΔCys612) mimicked the Cys-deficiency-induced loss of FoxO1 transactivation 
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activity. Moreover, mutation of the first six cysteine residues (FoxO1-ΔCys1-6) was without 
effect on FoxO1 transactivation activity (Fig. 17). Transfection efficiency was even regardless 
of the expression vector (Fig. 18). Cys612 located in the FoxO1 transactivation domain, 
which might explain its requirement for full activity (Fig. 7).  
 
Figure 18:  
Transfection efficiency of various FoxO1 constructs in HEK293 and HepG2 cells. Representative transfection 
efficiency of FoxO1 forms in HEK293 and HepG2 cells. V5 antibody was used to detect exogenous FoxO1; b-
actin was employed as a housekeeping protein. HEK293 or HepG2 cells were transfected with different FoxO1 
forms and thereafter the stimulation of FoxO1-responsive promoters was assessed using luciferase reporter assay. 
The same lysates obtained for the luciferase reporter assay were then analyzed by SDS-PAGE gel and transfection 
efficiency was studied using western blotting analysis. As a “control vector”, pCI Neo was employed. All FoxO1 
expression vectors were tagged with biotin and V5. Western blotting analysis was performed twice, using lysates 
obtained from different experiments.  
 
To assess whether loss of FoxO1 transactivation activity mediated by FoxO1 cysteine 
deficiency (Fig. 15) had an effect on FoxO1 activity, the expression levels of FoxO1 target 
genes, such as g6pc, selP, and foxo1, were studied (Fig. 19) [174, 193, 206]. To avoid “noise” 
caused by overepression of the exogenous FoxO1, specific primers for the 3’-UTR region 
were designed for detection FoxO1 mRNA.  
In line with the results obtained using the luciferase reporter assay, elevated expression 
levels of FoxO1 target genes due to FoxO1 overexpression was more prominent in cells 
transfected with WT FoxO1 as compared to those transfected with FoxO1-ΔCys1-7. Among 
all seven cysteines, mutation in the last FoxO1 cysteine residue (FoxO1-ΔCys612) induced 
effects similar to FoxO1-ΔCys1-7, whereas mutation of the other six FoxO1 cysteine residues 
(FoxO1-ΔCys1-6) had no effect on FoxO1 transactivation activity (Fig. 19). 
In summary, cysteine deficiency in FoxO1 affected neither its localization nor its DNA 
binding. In contrast, a single mutation in Cys612 of FoxO1 caused impairment of basal 
transactivation activity, which in turn led to impaired regulation of FoxO1 target genes. Since 
cysteine residues are known to mediate oxidative stress-induced interactions with co-factors 
such as CBP/p300, which reversibly interacts with FoxO1 and FoxO4 upon exposure to 
hydrogen peroxide, we investigated whether diamide-induced severe oxidative stress could 
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potentially trigger similar redox-sensitive interactions [177, 203]. Despite both hydrogen 
peroxide and diamide both depleting and oxidizing GSH, diamide seems to mediate more 
severe stressful conditions, which in turn could activate different signaling pathways, such as 
pathways towards apoptosis, as compared to hydrogen peroxide [214]. 
 
Figure 19:  
Expression of FoxO1 target genes in HEK293 and HepG2 cells, transfected with different FoxO1 forms. HEK293 
or HepG2 cells were transfected with different FoxO1 forms and thereafter the expression level of FoxO1 target 
genes was assessed using RT-qPCR. The respective mRNA level was normalized to HPRT1, which was used as a 
housekeeping gene, and thereafter the ratio obtained for WT FoxO1 was set to 100. As a “control vector”, pCI Neo 
was used. All FoxO1 expression vectors were tagged with biotin and V5. The expression of g6pc was not assessed 
due to low overall expression level in HEK293 cells. Data are presented as means +SD from 3 independent 
experiments. *a, p<0.001 as compared to control vector; *b, p<0.001 as compared to WT FoxO1; One-way Anova 
with Student-Newman-Keuls post-test. 
 
3.7 Viability reduction, depletion/oxidation of GSH, and FoxO1 nuclear accumulation  
induced by diamide  
 
Diamide is a well-known thiol oxidizing agent, which was reported to deplete and 
oxidize GSH [201]. To test whether GSH was indeed depleted/oxidized, HEK293 cells were 
treated with different diamide concentrations for 30 minutes and thereafter GSH levels were 
measured (Fig. 20). 
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Figure 20:  
GSH and GSSG levels upon diamide treatment in HEK293 cells. HEK293 cells were treated with different 
diamide concentrations for 30 minutes and thereafter (A.) total GSH and (B.) GSSG was measured enzymatically. 
As a control DMSO 0.1% v/v was employed. In case of diamide 2 mM, DMSO concentration was 0.2% v/v. GSH 
or GSSG/protein level ratios were calculated and normalized against the control, which was set to 100%. Data are 
presented as means +SD from 4 independent experiments. *p<0.05 as compared to control; ***p<0.001 as 
compared to control; Student´s t-test. 
 
Diamide successfully oxidized GSH to GSSG in a somewhat concentration-dependent 
way (Fig. 20). Interestingly, GSH was also depleted; presumably because of active 
GSH/GSSG secretion or formation of protein mixed-disulfides (S-glutathionylated proteins). 
Since the 2GSH to GSSG ratio was altered due to diamide treatment, the cellular state was 
altered. Imbalances in redox state could trigger cell death through ROS accumulation and we 
therefore investigated whether diamide was tolerated by HEK293 cells within the same 
concentration and time frame (Fig. 21).   
 
Figure 21:  
Viability of HEK293 cells upon diamide treatment. HEK293 cells were treated with different diamide 
concentrations for 30 minutes and thereafter cell viability was assessed by MTT conversion. As a control, DMSO 
0.1% v/v was employed. In case of diamide 2 mM, DMSO concentration was 0.2% v/v. DMSO control was set to 
100. Data are presented as means ±SD from 4 independent experiments. *p<0.05 as compared to control; Student´s 
t-test. 
 
Although exposure to diamide reduced viability in a concentration-dependent way in 
HEK293 cells, approximately 90% of the cells were still alive upon 1 mM diamide treatment 
(Fig. 21). Therefore, for the upcoming experiments the employed diamide concentration was 
as high as 1 mM. As a transcription factor, FoxO1 shuttles between the cytoplasm and 
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nucleus to regulate the transcription of its target genes. During oxidative stress, FoxO1 is 
predominately localized in the nucleus to promote the upregulation of genes related to 
antioxidant defense. To address that general observation and whether cysteine deficiency may 
alter that FoxO1 process, FoxO1 localization was assessed using HEK293 of HepG2 cells 
transfected with plasmids encoding either WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP (Fig. 
22). 
 
Figure 22:  
FoxO1 localization upon diamide treatment in HEK293 or HepG2 transfected cells. Examples of cells with WT 
FoxO1-EGFP distribution in compartments in (A.) HEK293 and (B.) HepG2 cells. Control and 1 mM diamide 
treatment are depicted in “i.” and “ii.”, respectively. (C.) Analysis of FoxO1-EGFP distribution among 
compartments. HEK293 or HepG2 cells were transfected with WT FoxO1-EGFP or FoxO1-ΔCys1-7-EGFP, 
treated with DMSO (0.1% v/v) or 1 mM diamide and thereafter FoxO1-EGFP distribution in compartments was 
assessed using fluorescence microscope. (C.) Data are presented as fractions of 100% of 3 independent 
experiments. In all case, SD was lower than 5% of the relative amount of cells, as were set to 100%. 
 
In line with the above statement, 1 mM diamide treatment promoted FoxO1-EGFP 
nuclear accumulation in HepG2 cells; it did so regardless of the presence or absence of 
FoxO1 cysteine residues. In contrast, the same treatment did not significantly alter FoxO1-
EGFP distribution in HEK293. A potential explanation might be that in comparison to a 
minor 4% nucleic FoxO1-EGFP in HepG2 cells under physiological conditions, 
approximately 40% of FoxO1-EGFP was already located in the nucleus in HEK293 under the 
same conditions. As a consequence, the nuclear FoxO1-EGFP in HEK293 cells was already 
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sufficient to promote upregulation of genes involved in antioxidant defense and therefore no 
additional FoxO1-EGFP nuclear accumulation was detected in HEK293 cells. Since in both 
cell lines FoxO1-EGFP nuclear accumulation was detected upon 1 mM diamide treatment, we 
investigated DNA binding ability of FoxO1 under the same conditions. 
 
3.8 C612-independent attenuation of FoxO1 DNA binding upon diamide treatment in 
HEK293 cells 
 
Using EMSAs, we assessed (a.) the general DNA binding ability of FoxO1 upon 
exposure to 1 mM diamide and (b.) FoxO1 cysteine residues may affect it. HEK293 cells 
were transfected with WT FoxO1-GFP or various cysteine-deficient mutants plasmids, 
including FoxO1-ΔCys1-7, FoxO1-ΔCys1-6, and FoxO1-ΔCys612 (Fig. 23).  
 
Figure 23:  
FoxO1 DNA binding in HEK293 transfected cells treated with diamide. Representative DNA binding of various 
FoxO1 forms in HEK293 cells upon 1 mM diamide treatment. HEK293 cells were transfected with WT FoxO1-
GFP or cysteine deficient FoxO1-GFP mutants. We then treated with DMSO (0.1% v/v) or 1 mM diamide for 30 
minutes, nuclear extracts were generated using a cell fractionation kit and thereafter DNA binding of FoxO1 was 
studied using EMSAs. Western blotting analysis was performed twice, using lysates obtained by different 
experiments.   
 
Exposure of cells to 1 mM diamide led to attenuated WT FoxO1 DNA binding, whereas 
no loss of binding was observed with FoxO1-ΔCys1-7. Surprisingly, FoxO1 DNA binding 
remained almost intact in FoxO1-ΔCys1-6, but was impaired wit FoxO1-ΔCys612 under 1 
mM diamide treatment (Fig. 23). Thus diamide-induced attenuation of FoxO1 DNA binding 
was Cys612-independent which was in contrast to Cys612-dependent loss of basal FoxO1 
transactivation activity (Fig. 17). To further elucidate the underlying mechanism causing the 
WT FoxO1 DNA binding attenuation, we tested whether S-glutationylation could be 
involved. To investigate that hypothesis we initially assessed whether (a.) diamide could 
promote S-glutathionylation (Fig. 24) and (b.) impaired WT FoxO1 DNA binding could be 
restored by reversing S-glutathionylation (Fig. 26). 
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3.9 Diamide-induced protein S-glutathionylation in HEK293 cells 
 
Protein S-glutathionylation is a reversible post-translational modification occurring 
under oxidative/nitrosative stress, but rarely also under physiological conditions. Upon 
oxidative/nitrosative stress, GSH may form a disulfide bridge with a cysteine residue of a 
protein and thus protect the redox sensitive cysteines from irreversible oxidation which in turn 
could lead to protein degradation (Chapter 1.6.2.2.1). As a thiol oxidizing agent, diamide 
could presumably have induced protein S-glutathionylation to affect FoxO1, and we thus 
tested that hypothesis (Fig. 24) [214]. 
 
Figure 24:  
Induction of S-glutathionylation upon diamide treatment in HEK293 transfected cells. Representative western blot 
related to diamide-promoted protein S-glutathionylation in HEK293 cells transefected with either WT FoxO1 or 
FoxO1-ΔCys1-7. Cells were treated with DMSO (0.1% v/v) or 1 mM diamide and lysed in RIPA buffer. Lysates 
were then analyzed by SDS-PAGE both under non-reducing and reducing conditions. Under reducing conditions, 
formation of protein S-glutathionylation was abolished. As loading control, the housekeeping protein b-actin was 
employed. FoxO1 expression vectors were tagged with biotin and V5. The data are representative of 5 independent 
experiments.   
 
Indeed, exposure to 1 mM diamide promoted protein S-glutathionylation in transfected 
HEK293 cells, as detected under non-reducing conditions. As expected, the detected signal 
vanished in the presence of a reducing agent, such as β-mercaptoethanol (Fig. 22). As already 
mentioned, induction of protein S-glutathionylation might explain GSH depletion (Fig. 19), 
without excluding the probability of active secretion of GSH/GSSG. Since diamide treatment 
induced protein S-glutathionylation, we then tried to reverse the post-translational 
modification. To achieve that, two different approaches were tested: (a.) simple recovery and 
(b.) Grx-1 overexpression. 
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3.10 Attenuation of FoxO1 DNA binding by diamide is mediated by S-glutathionylation 
in HEK293 cells  
    
An important asset of S-glutathionylation is the reversibility of this modification by 
Grxs. To examine whether diamide-induced S-glutathionylation is reversible and could be 
recovered by endogenous Grxs, HEK293 cells were left to recover in the absence of diamide. 
To elucidate whether Grxs accelerated reversion of S-glutathionylation, we overexpressed 
Grx-1, a key Grx capable of reversing S-glutathionylation (Fig. 25). Grxs were reported to 
utilize the monothiol pathway to promote deglutathionylation [102]. To verify that, two Grx-1 
mutants were generated in which either Cys23 (Grx-1-ΔCys23) or Cys26 (Grx-1-ΔCys26) 
was mutated to serine. 
 
Figure 25:  
Reversibility of protein S-glutathionylation in HEK293 cells. (A. B.) Representative western blotting analysis of 
HEK293 cells transfected with empty vector or variants of Grx-1; (A.) Grx-1-ΔCys23 and (Β.) Grx-1-ΔCys26. (C.) 
Representative western blotting analysis of HEK293 cells recovering in absence of diamide (D.) Densitometric 
analysis of (A.) and (B.) Following a 30-minute exposure to DMSO (0.1% v/v) or 1mM diamide, cells were left to 
recover in absence of the compound for up to (A. B.) 30 minutes or (C.) 60 minutes. Cells were then lysated, 
analyzed by SDS-PAGE and S-glutathionylation induction was assessed using western blotting analysis. Grx-1 
variants were tagged with myc. (A.) and (B.) were performed twice. (C.) was repeated thrice. (D.) Densitometric 
signal of an entire line was normalized to b-actin, a housekeeping protein. Thereafter, the ratio acquired for 1 mM 
diamide was set to 100. Data are presented as mean +max of 2 independent experiments. 
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Protein S-glutathionylation was indeed rapidly reversed; after just five minutes of simple 
recovery the majority of the proteins were back to their physiological non-S-glutathionylated 
form (Fig. 25C). Overexpression of Grx-1 somewhat accelerated deglutathionylation as 
compared to cells overexpressing the control vector. In line with previous reports, in cells 
transfected with Grx-1-ΔCys23 [103, 106], Grx-1 overexpression-induced acceleration of 
deglutathionylation was attenuated, meaning that Cys23 (Fig. 25A) was the important Grx-1 
cysteine residue in inducing reversibility of S-gluathionylation. Therefore, we investigated 
whether attenuation in DNA binding of WT FoxO1 was potentially mediated by S-
glutathionylation (Fig. 26). 
 
Figure 26:  
Contribution of S-gluathionylation to attenuated DNA binding of WT FoxO1. (i.) Representative EMSA blot of 
HEK293 cells co-transfected with WT FoxO1 and either control vector or Grx-1 variants. (ii.) Densitometric 
analysis of EMSAs. HEK293 cells were transfected with WT FoxO1 and (A.) control vector or Grx-1 and (B.) 
control vector and Grx-1 variants. After exposure to DMSO (0.1% v/v) or 1 mM diamide, cells were recovered for 
up to 30 minutes and thereafter nuclear extracts were generated a using cell fractionation kit. DNA binding of 
FoxO1 was then analyzed using EMSA. WT FoxO1 was labeled with GFP; Grx-1 variants were tagged with myc 
(ii.) Band density was assessed and control (DMSO) was then set to 100. Data are presented as (A.) mean +SD of 
3 and (B.) mean +max of 2 individual experiments. (A. ii.) *a, p<0.001 as compared to 1 mM diamide; *b, 
p<0.001 as compared to control; *c, p<0.001 as compared to 1 mM diamide and p<0.001 as compared to 30’ 
recovery of the control vector; One-way Anova with Student-Newman-Keuls post-test. 
 
Initially, DNA binding of WT FoxO1 was restored after 30 minutes recovery in HEK293 
cells transfected with the control vector. Grx-1 overexpression not only somewhat alleviated 
the diamide-induced attenuation of WT FoxO1 DNA binding but additionally accelerated the 
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recovery of the impaired DNA binding of WT FoxO1 as compared to control vector (Fig. 
26A). In addition to the observation that mutation of Cys23 of Grx-1 (Grx-1-ΔCys23) 
reversed the Grx-1-mediated acceleration in DNA binding recovery; mutation in Cys26 of 
Grx-1 (Grx-1-ΔCys26) did not affect the Grx-1-induced effect (Fig. 26B), implying that S-
gluathionylation might be the key modification causing the attenuation. Since protein S-
gluathionylation was found to be involved in the DNA binding attenuation of WT FoxO1, we 
further asked whether FoxO1 is potentially S-glutathionylated (Fig. 27). 
 
3.11 Is FoxO1 a potential direct target of GSH under diamide-induced oxidative stress? 
 
As revealed through EMSAs, the diamide-induced attenuation of WT FoxO1 DNA 
binding was mediated by S-glutathionylation. We therefore investigated whether GSH may 
directly bind to a random FoxO1 cysteine residue and induce FoxO1 S-gluathionylation. To 
address that, a pull down of biotinylated FoxO1 using streptavidin beads in cell lysates 
obtained from HEK293 cells transfected with biotinylation signal-containing WT FoxO1 or 
FoxO1-ΔCys1-7 was employed followed by GS-protein detection (Fig. 27). 
 
Figure 27:  
Diamide-driven protein complex that contains WT FoxO1. Representative western blots of (A.) detection of 
exogenous FoxO1 variants or (B.) detection of GS-proteins after streptavidin pull down are depicted. HEK293 
cells were transfected with WT FoxO1 or FoxO1-ΔCys1-7, tagged with biotin and V5. Thereafter, the transfected 
cells were exposed to DMSO (0.1% v/v) or 1 mM diamide for 30 minutes and lysed in RIPA buffer. Streptavidin 
beads were employed in 100 μg of total protein and biotinylated FoxO1 was pulled down. Lysates were then 
analyzed by SDS-PAGE and the status of biotinylated FoxO1 was assessed using western blotting analysis. 
Western blotting was performed twice with different lysates. 
 
Upon diamide treatment WT FoxO1, but not FoxO1-ΔCys1-7, was in a protein complex 
with an unknown co-factor under non-reducing conditions. Reducing conditions abolished 
diamide-induced protein complex, which in line with the observation related to FoxO1-
ΔCys1-7, led to the hypothesis that diamide-mediated WT FoxO1 interaction with an 
unknown factor was dependent on cysteine residues of FoxO1 (Fig. 27A). That observation is 
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somewhat in line with previous reports of FoxO1 being in protein complex upon exposure to 
hydrogen peroxide [203]. Immunoblotting of S-glutathionylated proteins revealed that the 
protein complex is potentially S-gluathionylated. Surprisingly, an additional band was 
detected in case of FoxO1-ΔCys1-7 (Fig. 27B). One possible explanation might be that 
streptavidin beads could potentially pull down endogenous biotinylated proteins, such as 
acetyl-coA carboxylase, which could be either directly S-glutathionylated or in a protein 
complex with an S-glutathionylated co-factor. 
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4. Discussion  
 
The tripeptide, GSH, is the major cellular non-enzymatic ROS scavenger and the ratio of 
its redox couple [2GSH]/[GSSG] is frequently employed to assess the cellular redox state 
[100, 109]. Although the pivotal role of GSH in ROS elimination and the ROS-mediated 
modulation of FoxOs are well reported, a direct correlation between GSH and FoxO 
modulation has not been investigated. Herein, we attempted to elucidate such an interaction 
both in vivo and in vitro. Exposure of C. elegans with a thiol-modulating agent (DEM) 
revealed that total thiol amounts were successfully reduced. On top of that, to investigate 
whether glutathione may modulate FoxO transcription factors, depletion of gcs-1 was 
employed in C. elegans. In an attempt to mimic the DEM interaction with the protein thiol 
(cysteine) residues, cysteine residues of our protein of interest, FoxO1, were mutated. 
However, depletion of gcs-1 may not simulate modifications that require GSH molecules, 
such as S-gluathionylation, a post-translational modification in which GSH forms a disulfide 
bridge with a cysteine residue of a protein. Therefore, we employed a thiol oxidizing agent, 
diamide, in vitro. 
 
4.1 DEM-mediated alteration of thiol status affects C. elegans life span 
 
 C. elegans, a model organism frequently employed in study of ageing, was used for our 
in vivo experiments. Thiol modulating compounds were previously shown to affect C. elegans 
life span. One of the compounds, plumbagin, induced a life span extension when applied at 
low concentrations but had a lethal effect at higher concentrations [215]. Plumbagin-induced 
biological actions have been proposed to be related to alterations in cellular thiols, rather than 
in ROS accumulation [216]. Similarly to the effect of plumbagin, mild DEM-induced thiol 
depletion led to a hormetic effect on C. elegans life span (Fig. 9B). Low DEM concentrations, 
up to 100 μM, may initiate an adaptive response, which in turn elevated stress resistance and 
promoted life span extension in C. elegans (Fig. 9A). In contrast, higher DEM concentrations 
may have caused extensive ROS accumulation, inducing severe oxidative stress and 
subsequently life span shortening in C. elegans (Fig. 9A). 
 
4.2 DEM-induced hormetic effect mediated by DAF-16 and SKN-1 
 
Two transcription factors involved in adaptive processes induced upon oxidative stress 
where found to mediate the DEM-induced deceleration of C. elegans ageing; DAF-16 and 
SKN-1. In daf-16 or skn-1-deficient strains, the 100 μΜ DEM-mediated effect was abolished, 
leading to the assumption that both transcription factors are required to enhance C. elegans 
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life span (Fig. 12). In line with that, exposure of wild type nematodes to 100 μΜ DEM 
induced upregulation of ctl-1, sod-3, and gei-1, which are predominantly regulated by DAF-
16 (Fig. 11A-C) [60, 62]. In addition, the expression level of SKN-1 regulated genes, more 
specifically gcs-1, gst-4, and gst-10, was also elevated (Fig. 13E-G) [76]. The enhanced 
expression level of the above-mentioned genes, ctl-1, sod-3, gcs-1, gst-4, and gst-10, 
including the increased ctl-2 expression level, which is transcriptionally regulated by both 
DAF-16 and SKN-1, may explain the adaptive response upon treatment with 100 μΜ DEM, 
since all the above target genes play a pivotal role in antioxidant defense. In contrast, 
administration of 1 mM DEM did not significantly alter the expression level of genes 
regulated by DAF-16 or SKN-1, but led to upregulation of egl-1, a target gene regulated by a 
p53-orthologue, which could serve as indicator for initiation of the apoptotic process in C. 
elegans (Fig. 13H) [211]. In contrast to the observed general pattern of gene regulation, 
treatment with 1 mM DEM induced more profound DAF-16 nuclear accumulation as 
compared to 100 μΜ DEM, meaning that DAF-16 might be inactive despite translocating to 
the nucleus upon exposure to 1 mM DEM [204]. A potential explanation of an inactive DAF-
16 form trapped into the nucleus could be the nuclear export machinery malfunction driven 
by DEM treatment, which has previously reported in mammalian cells [217]. Although 
alterations were detected with regard to DAF-16 and SKN-1, DEM treatment with 
concentrations between 100 μM and 1 mM led to non-concentration dependent thiol or GSH 
depletion, meaning that the DEM-mediated hormetic effect should not entirely depend on 
thiols or GSH depletion (Fig. 28). 
The term “hormesis” was first introduced in 1943 by Southam et al. and can be defined 
as “beneficial effects of low doses of substances or interventions known to be toxic at higher 
doses” [218]. Although the term was introduced long ago, hormesis was first used as 
mechanism underlying decelaration of C. elegans ageing around 1994 [219]. In later years, 
there was a hypothesis that exposure to mild oxidative stress could activate DAF-16, which in 
turn could initiate the transcriptional regulation of genes encoding antioxidant defense 
enzymes, such as SOD and catalases. Activation of antioxidant enzymes could eventually 
mediate an adaptive response which in turn would initiate less susceptibility to subsequent 
intense stress and therefore enhance C. elegans life span. Indeed, a growing body of evidence 
reports that DAF-16 is activated upon mild oxidative stress and thus DAF-16 was 
demonstrated to be involved in hormesis-mediated life span extension. For instance, daf-16 
was shown to be required for a hormesis-induced deceleration of ageing in nematodes in 
which thermotolerance was mediated by pre-treatment with sub-lethal heat [219, 220].  By 
activating DAF-16, low-doses of juglone elevated stress resistance and in turn increased life 
span in C. elegans [221, 222]. Lastly, low-doses of the green tea flavonoid, epigallocatechin 
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gallate did not significantly generate hydrogen peroxide but enhanced C. elegans life span 
while upregulating the expression of sod-3 [223]. 
 
Figure 28:  
Non-linear effect mediated by DEM on C. elegans life span. DEM-induced mild thiol depletion promotes hormetic 
effect in C. elegans. Low DEM concentrations enhance stress resistance and in turn deceleration in ageing of C. 
elegans. DEM-mediated adaptive response was promoted by elevated expression levels of genes predominantly 
regulated by DAF-16 or SKN-1. In contrast, high DEM concentrations did not significantly induce upregulation of 
DAF-16 and/or SKN-1 target genes and thus severe induction of stress promoted acceleration of C. elegans 
ageing. 
 
4.3 Genetic manipulation of gcs-1 results in upregulation of genes of the thioredoxin-
dependent-redox system 
 
As previously mentioned, mild GSH depletion mediated by either exposure to low DEM 
concentrations or by gcs-1 depletion extended C. elegans life span [204]. That observation 
was in contrast to previous reports in which direct supplementation with a GSH derivative or 
low juglone concentration, leading to elevated GSH level, may increase life span and stress 
resistance through DAF-16 activation in C. elegans [221, 222]. Depletion of gcs-1 starting at 
L4 larvae stage induced profound upregulation of genes related to thioredoxin-dependent 
redox system, such as trx-1, trxr-1, and trxr-2 (Fig. 14E-G) [212]. In addition to enhanced 
gene expression of the thioredoxin system, gst-4 and mtl-1 levels were also elevated (Fig. 
14D and H) [76, 213]. Upregulation of genes contributing in maintenance of redox status 
could mediate a protective response in mild GSH depletion, which in turn may increase life 
span of nematodes with impaired gcs-1 expression. In contrast to the life span-extending 
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effect induced by low DEM concentrations, gcs-1 knockout did not statistically significantly 
alter either DAF-16 nucleocytoplasmic shuttling or regulation of DAF-16 target genes, 
meaning that GSH depletion may not directly contribute to deceleration of C. elegans ageing 
with regard to DAF-16 modulation [204]. However, it should be noted that genetic GSH 
depletion may not successfully simulate GSH-driven post-translational modifications in 
which the GSH is required, such as in S-glutathionylation. 
 
4.4 Cys612-dependent loss of basal transactivation activity of FoxO1 
 
Cysteine residues of FoxO proteins were previously demonstrated to have an important 
role in regulation of FoxO activity under stressful conditions, predominantly induced by 
exposure to hydrogen peroxide. Initially, hydrogen peroxide-induced acetylation of FoxO4 
was shown to be induced by cysteine-dependent interaction with CBP/p300 [177]. In 
addition, FoxO4 nucleocytoplasmic shuttling mediated by hydrogen peroxide was reported to 
be promoted by cysteine-dependent interaction with Transportin-1. Interestingly, the 
underlying mechanism was highly conserved in C. elegans [224]. In a similar manner, nuclear 
import receptors, Importin-7 and Importin-8, formed a cysteine-dependent interaction with 
FoxO3a, promoting FoxO3a nuclear translocation upon exposure to hydrogen peroxide [202]. 
Recently, it was also proposed that, similar to FoxO4 acetylation, cysteine-dependent 
interaction of FoxO1 with CBP/p300 might promote hydrogen peroxide-driven FoxO1 
acetylation. The above-mentioned interaction was potently blocked by thioredoxin [203].  
In an attempt to mimic DEM-mediated formation of adducts with cysteine residues of 
proteins, we genetically manipulated FoxO1 cysteine residues. In HEK293 or HepG2 cells 
transfected with WT FoxO1 or FoxO1-ΔCys1-7, neither FoxO1 nucleocytoplasmic 
distribution nor FoxO1 DNA binding was affected under basal conditions (Fig. 16 and Fig. 15 
respectively). The observation regarding the cytoplasmic-nuclear shuttling was expected since 
cysteine residue-driven alterations in FoxO1 distribution through post-translational 
modifications, such as acetylation mediated by CBP/p300, usually required a stimulus, such a 
hydrogen peroxide, to initiate the entire process. In addition, no cysteine residue is located in 
the DNA binding domain of FoxO1 which could potentially induce attenuation of basal 
FoxO1 DNA binding. However, loss of FoxO1 basal transactivation activity was detected and 
was shown to be mediated by a single mutation in Cys612 (FoxO-ΔCys612) (Fig. 17), which 
is located in the transactivation domain of FoxO1. Interestingly, Cys612 is highly conserved 
among FoxO isoforms and is responsible for cysteine-dependent interactions induced in 
FoxO3a and FoxO4 upon exposure to hydrogen peroxide [177, 184] Although the underlying 
mechanism remains elusive, we hypothesize that mutation in Cys612 somewhat mimics 
cysteine oxidation which could potentially diminish FoxO1 transactivation activity (Fig. 29). 
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Such incident has been reported in case of p53, in which direct cysteine oxidation can block 
DNA binding and transactivation activity [225, 226]. In line with the loss of FoxO1 
transactivation activity, upregulation of FoxO1 target genes stimulated by transfection of 
FoxO1 forms was less prominent in cells transfected with FoxO1-ΔCys612 as compared to 
WT FoxO1 (Fig. 19). Albeit FoxO1-ΔCys612 overexperssion stimulated the expression of 
FoxO1 target genes less efficiently as compared to the WT FoxO1, overexperssion of FoxO1-
ΔCys612 significantly elevated the expression levels of the target genes as compared to the 
control vector (Fig. 17). That significant elevation was dependent on some residual 
transactivation activity, accompanied with the unaffected DNA binding of the FoxO1-ΔCys1-
7 (Fig. 15).   
 
4.5 Cys612-independent attenuation of WT FoxO1 DNA binding upon diamide 
treatment  
 
Hydrogen peroxide is one of the most frequently employed ROS forms to investigate 
FoxO regulation induced by ROS-mediated interactions. Herein, we employed a thiol 
oxidizing agent, diamide, to test whether FoxO1 activity is affected under stressful conditions. 
Diamide was reported to promote more severe oxidative stress and enhanced protein S-
glutathionylation as compared to hydrogen peroxide [214]. Exposure to 1 mM diamide 
induced WT FoxO1 DNA binding attenuation, which was less prominent in FoxO1-ΔCys1-7. 
It should be noted that diamide-driven attenuation was independent of Cys612 (Fig. 23). 
Interestingly, the FoxO1 DNA binding domain does not harbor any cysteine residues. 
Reversing diamide-induced S-glutathionylation through (a.) recovery in the absence of 
diamide or (b.) Grx-1 overexpression recovered DNA binding of FoxO1 (Fig. 25). More 
importantly, the observed recovery was independent of Cys26, but dependent on Cys23 of 
Grx-1 (Fig. 25B) which is in line with the monothiol mechanism of Grx-1 in mediating 
degluathionylation, meaning that S-gluathionylation mediated the impaired FoxO1 DNA 
binding upon exposure to diamide [103, 106]. A similar mechanism in DNA binding 
inhibition driven by S-glutathionylation was reported in other transcription factors, such as in 
p53. [227]. It should be noted that all p53 cysteine residues are located in its DNA binding 
domain, which is in contrast to the absence of cysteine residues located in the FoxO1 DNA 
binding domain. 
In addition to S-glutathionylation-induced DNA binding attenuation of FoxO1 upon 
exposure to diamide, WT FoxO1 was in a protein complex dependent on its cysteine residues 
(Fig. 26A). Preliminary data reveal that the creation of this protein complex is independent of 
Cys612 (data not shown), which is in line with the Cys612-independent attenuation in DNA 
binding of WT FoxO1 (Fig. 23). Cys612-independent interaction of WT FoxO1 with an 
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unknown factor upon diamide treatment was in contrast to the recently reported interaction of 
FoxO1 with CBP/p300 upon exposure to hydrogen peroxide [203]. Indeed, a pull down of 
biotinylation signal-containing WT FoxO1 failed to co-precipitate down CBP/p300 (data not 
shown), which led us to the hypothesis that diamide may mediate different interactions as 
compared to hydrogen peroxide. The diamide-driven protein complex seemed to be S-
glutathionylated (Fig. 26B); however, we should also keep in mind that another endogenous 
biotinylated protein which is directly S-glutathionylated or in a protein complex with an S-
glutathionylated co-factor might also be pulled down by streptavidin beads. Although the 
underlying mechanism is still not understood, glutathione could mediate redox regulation of 
FoxO1 through S-glutathionylation (Fig. 29).   
 
Figure 29:  
Cysteine-driven regulation of FoxO1. Under basal conditions, mutation of Cys612 in FoxO1 impaired 
transactivation activity of FoxO1, which in turn promoted inefficient stimulation of the expression of FoxO1 target 
genes as compared to WT FoxO1. In contrast to the role of Cys612 on the loss of FoxO1 basal transactivation 
activity, a Cys612-independent interaction with either (A.) glutathione induced FoxO1 S-glutathionylation or (B.) 
an unknown S-gluathionylated factor promoted, attenuated WT FoxO1 DNA binding upon exposure to diamide. 
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4.6 Alterations in the redox status of proteins/kinases acting upstream of FoxO 
transcription factors mediated by the thioredoxin or glutaredoxin system 
 
Although attenuated WT FoxO1 DNA binding was mediated by S-glutathionylation, 
which was hypothesized to act immediately on FoxO1 (Fig. 26), we should also consider the 
possibility that S-glutationylation or redox changes mediated by the thioredoxin system may 
affect the redox status of proteins/kinases which in turn could influence the activity of FoxO 
transcription factors.  
For example, Trx overexpression was reported to mediate the phosphorylation of MKK4 
and MKK7, which are upstream kinases of the JNK signaling cascade, inducing its activation. 
JNK activation initiated phosphorylation of cJun, Jun B, and Fra-1, which were then recruited 
in a protein complex with AP-1 and thus promoted AP-1 DNA binding [228]. JNK-mediated 
phosphorylation of FoxOs was demonstrated to have either activating or inactivating role in 
the case of FoxO4 or FoxO3a, respectively [161, 229].  
As already mentioned, phosphorylation of Akt promotes phosphorylation/inactivation of 
FoxO transcription factors (Fig. 3). The redox state of Akt was reported to be regulated 
through glutaredoxin; hydrogen peroxide-driven oxidation of Akt was alleviated by Grx 
overexpression, leading to inhibition of apoptosis [230]. Therefore, regulation of Akt might 
also occur through S-glutathionylation. In addition, several other signaling proteins 
interfering with changes in Akt activity, such as PTEN, protein phosphatase 2 (PP2A), and 
apoptosis signal-regulating kinase 1 (ASK-1), were reported to be regulated by S-
glutathionylation [147].  
Lastly, the insulin signaling cascade, downstream of which FoxO transcription factors 
are regulated, was shown to be negatively regulated by protein tyrosine phosphatases (PTP)-
1B [231]. A growing body of evidence shows that reversible oxidation at Cys215 of the active 
site of PTP1B mediated by S-glutathionylation initiates the inactivation of PTP1B [232, 233]. 
For instance, such an interaction may explain the accelerated recovery of WT FoxO1 DNA 
binding upon Grx-1 overexpression. Overexpression of Grx-1 could initiate S-
gluathionylation reversibility, which in turn could mediate PTP-1B reactivation. Upon PTP-
1B reactivation, insulin pathway would be inhibited and thus would allow WT FoxO1 to 
successfully bind to DNA. 
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5. Conclusion  
 
FoxO transcription factors were previously demonstrated to be regulated by stressful 
stimuli eliciting elevation in ROS levels [155]. Although ROS-driven modulation of FoxOs is 
well documented, the role of glutathione on FoxO transcription factor activity was never 
directly investigated before. In vivo mild depletion of glutathione by targeting gcs-1, the 
enzyme catalyzing the rate-limiting step in glutathione synthesis, did not affect the regulation 
of DAF-16 target genes, such as sod-3 and ctl-1, which was in line with the predominant 
cytoplasmic retention of DAF-16 in C. elegans. 
In contrast to the results obtained by gcs-1 depletion in C. elegans, in vitro GSH 
depletion/oxidation mediated by diamide attenuated WT FoxO1 DNA binding. Interestingly, 
overexpression of Grx-1 accelerated the recovery of WT FoxO1 to bind in DNA, indicating 
that interference with glutathione mediated the diamide-driven attenuation of WT FoxO1 
DNA binding. In addition, employment of Grx-1 mutants (Grx-1-ΔCys23 and Grx-1-ΔCys26) 
revealed that S-glutathionylation was responsible for the observed attenuation. As already 
mentioned above, a possible explanation for the acquired contradictory results between the in 
vivo and in vitro approaches could be rest to the inability of gcs-1 inhibition to mimic 
processes that require oxidized GSH, such as in the case of S-glutathioynlation. 
In summary, this work has established that GSH levels affect FoxO activation and S-
glutathionylation contributes to the regulation of FoxO activity. Nevertheless, several 
questions are still unanswered, such as: Is WT FoxO1 directly S-glutathionylated or is the 
attenuation in FoxO1 DNA binding through a cysteine-dependent interaction with an 
unknown S-glutathionylated co-factor? Which FoxO1 cysteine residue is important for the 
diamide-induced consequences? Could Grx-1-driven acceleration in WT FoxO1 DNA 
binding recovery be mediated by S-glutathionylation occurring in another protein, such as Akt 
or PTP-1B, regulating FoxO1 activity? Is the attenuation exclusively mediated by diamide 
treatment? Whatever the outcome, it has been firmly established here that glutathione may 
interfere with the redox regulation of FoxO1.  
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